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Abstract 
Uncovering the Signaling Mechanisms of TransMEMbrane 16A  
 
Maiwase Tembo, PhD 
 
University of Pittsburgh, 2020 
 
 
 
 The Ca2+-activated Cl- channel, TransMEMbrane member 16A (TMEM16A), regulates 
diverse physiological functions including smooth muscle contraction, mucosal secretion and signal 
transduction. TMEM16A is an essential protein that we cannot live without. In fact, changes that 
enhance or reduce TMEM16A’s activity result in diseases such as hypertension and inflammatory 
airway diseases, respectively. Despite its importance, we are just beginning to understand how 
TMEM16A channel activity is regulated. To study TMEM16A’s regulation, I used 
electrophysiology techniques. Specifically, I recorded endogenous TMEM16A currents from 
Xenopus laevis oocytes using the inside-out configuration of the patch clamp technique. I observed 
that TMEM16A-conducted currents diminished within seconds of patch excision despite the 
continued presence of Ca2+. Current rundown is common amongst channels regulated by the fatty 
acid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). I demonstrated that TMEM16A current 
depletion in the membrane patch was due to loss of PI(4,5)P2, thereby revealing that PI(4,5)P2 is 
required for TMEM16A to conduct Cl- currents. Because PI(4,5)P2 is just one of eight cell 
membrane phosphoinositides that share a common backbone but differ in phosphate group number 
and location on the inositol ring, I sought to determine which features of PI(4,5)P2 enabled the 
lipid-channel interaction. I found that PI(4,5)P2 recovered the most current compared to the other 
phosphoinositides, and phosphoinositides containing at least one phosphate group on position 4 
were capable of recovering intermediate levels of current. The extent of recovery was dependent 
on whether or not the phospholipid included a phosphate at position 4 rather than the number of 
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negatively charged phosphates. In a separate line of experimentation, I determined that the rate of 
current rundown was influenced by the concentration of Ca2+ applied to excised patches in a way 
that activates a Ca2+-sensitive phospholipase C (PLC) to then deplete PI(4,5)P2. Taken together, 
my data reveal that PI(4,5)P2 regulates TMEM16A, and that the phosphate at position 4 is key in 
this interaction. Overall, my work revealed key mechanisms in how signals other than intracellular 
Ca2+ alter opening and closing of these critical channels. Expanding our understanding of 
TMEM16A’s regulatory mechanisms may lay the foundation for developing novel therapeutics 
for TMEM16A-associated diseases. 
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1.0 Introduction 
Ion signaling is fundamental to cellular function in all tissues and essential for survival in 
living organisms. This is true for organisms ranging from bacteria whose ability to adapt to 
different ionic environments is key to their survival [1] to humans whose neuronal firings rely on 
ionic gradients for proper brain function [2, 3]. In fact, our ability to experience the world relies 
on ion signaling. To feel the excruciating pain of knocking a toe against a bed post or hear the 
beautiful sound of Whitney Houston’s “I’m every woman” exploding into a room, ion transport 
must take place. To respond to these sensory stimuli accurately, one can imagine that cells must 
tightly regulate ion transport. Cells do so by building concentration gradients that are kept in 
homeostatic balance. Shifting ionic gradients allows for ion signaling that can be translated into 
us sensing our environments, the body’s physiologic functions and some voluntary actions. Even 
though ion signaling is crucial for our existence and that of other organisms, maintaining optimal 
cellular ion concentrations is difficult given the ion-impermeable lipid bilayers that surround cells.  
To traverse this barrier, cells have proteins embedded in these lipid bilayers to traffic ions 
across membranes. The three common classes of ion transport proteins are transporters, adenosine 
triphosphate (ATP)-powered pumps (ATPases) and ion channels [4] which can be in membranes 
of the cell and/or a cell’s internal organelles. These transport proteins play an important role in 
controlling the timing and direction of ion transport and ultimately, ion signaling. Following the 
appropriate signals, transport proteins can determine how fast an ion is transported and for how 
long. Additionally, each ion has an electrochemical potential or driving force [5] determining how 
hard it is to add more of that ion to a particular space. This results in transport proteins either 
working with or working against the ionic driving forces. Therefore, cells must also regulate the 
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transport proteins. With proper regulation, each transport protein plays distinct but instrumental 
roles that at times can even be collaborative.  
1.1 Ion transport proteins 
1.1.1 Transporters  
Transporters, sometimes referred to as carriers, move a variety of ions across the membrane 
[4]. Transporters are classified into three groups: uniporters, symporters and antiporters. 
Uniporters transport a single molecule such as glucose or amino acids down their concentration 
gradient [4]. By contrast, symporters and antiporters couple the movement of one type of ion or 
molecule against its concentration gradient with the transport of a different ion down its 
concentration gradient [4]. The couplings of different ion transports can happen in the same 
direction  as is observed in symporters or it can happen the in the opposite direction as is observed 
in antiporters [4]. An example of this family of proteins include ATP-binding cassette (ABC) 
transport proteins such as the multidrug resistance permeability glycoprotein 1 (PGY1) known to 
confer resistance to a hydrophobic cancer treatment drug in tumor cells [6]. 
1.1.2 ATP-powered pumps (ATPases) 
ATPases use the energy derived from the hydrolysis of ATP to move ions or small 
molecules across membranes against their concentration gradients and/or electrical potentials [4]. 
Similar to antiporters and symporters, ATPases conduct coupled transport in that they 
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simultaneously hydrolyze ATP into adenosine diphosphate (ADP) with ion transport [4]. However, 
ATPases rely on ATP hydrolysis for energy whereas antiporters and symporters rely on the 
electrochemical gradient of the ions being transported [4]. Examples of this class of proteins 
include the gastric H+/K+-ATPase that maintains intestine acidity levels [7] or the 
sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) known to transport Ca2+ from the 
sarcoendoplasmic reticulum cytosol to the lumen in myocytes [8]. 
1.1.3 Ion channels 
Ion channels transport ions down their electrochemical gradients. Channels are precisely 
embedded in the membrane to create a hydrophilic pore that allows the rapid movement of ions 
[4]. Some channels are kept open more regularly than others whereas other ion channels require a 
signal that is either electrical or chemical for the channel to open its pore and allow ion movement 
[4]. The opening and closing of ion channels is referred to as gating. The ability of an electrical or 
chemical signal to open an ion channel makes that channel gated by that signal. For example an 
ion channel opened by changes in voltage is referred to as voltage gated and an ion channel opened 
by a ligand binding is called ligand gated [9]. Upon signal induction, ion channel kinetics are 
1,000,000 times faster than ATPases or transporters [10]. They can transport many ions after 
receiving a single signal. Interestingly, many now think of ion channels and transporters as quite 
similar and only distinguished by their kinetics [11]. Ion channels are able to function because 
transporters (as well as ATPases) create the concentration gradients driving ions through open 
channels [12]. Whether the ion channels are voltage-gated, ligand-gated, stretch- or heat-activated 
[12], ion channels are not just essential for physiologic function, they are the spark of life. They 
are working even at this very moment to generate the electrical signals needed to get through this 
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page-turner from having relayed the idea of turning the page to the muscle movement used to 
accomplish this task. An example star player of this class of proteins is TransMEMbrane member 
16A (TMEM16A), a widely expressed Cl- channel that we cannot live without, and the channel I 
will discuss in this dissertation.  
1.2 TMEM16A discovery, physiology and structure-function 
1.2.1 Importance of TMEM16A in physiology  
TMEM16A is an evolutionarily conserved ion channel expressed in many cell types. 
Species including the zebrafish Danio rerio, aardvark Orycteropus afer, African clawed frog 
Xenopus laevis, and humans Homo sapiens have TMEM16A. TMEM16A is widely expressed in 
different cell types including smooth muscle cells of the cardiovascular system [13], dorsal root 
ganglion (DRG) neurons [14], airway epithelial cells [15] and renal epithelial cells [16]. In each 
of these cells, TMEM16A plays a fundamental role in the physiologic processes carried out by 
these cells.  
In the cardiovascular system, TMEM16A regulates vascular smooth muscle tone [13, 17]. 
Because vascular tone determines blood vessel caliber, a healthy cardiovascular system requires 
properly functioning TMEM16A channels. Properly functioning TMEM16A channels enable 
blood vessels that are constantly undergoing series of vasoconstrictions and vasodilations to 
respond to our physiological needs such as a fight or flight response with controlled opening and 
closing of TMEM16A [17]. However, when TMEM16A channels are constitutively open this 
causes excessive vasoconstriction (Figure 1-1A). Excessive vasoconstriction or hypertension is 
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itself a gateway and a mortality increasing factor for other cardiovascular diseases such as coronary 
heart disease and stroke [18]. Therefore, properly functioning TMEM16A protects us against 
cardiovascular disease. 
In DRG neurons, TMEM16A-conducted currents signal nociception. DRG neurons have a 
higher intracellular Cl- concentration that helps maintain their resting potential at approximately -
60 mV [19, 20]. Upon TMEM16A activation, Cl- exits the neuron to depolarize the membrane to 
approximately -20 mV (Figure 1-1B). [20]. This depolarization by TMEM16A is thought to be 
stimulated by the signaling of the G-coupled protein receptor for the peptide bradykinin [21] whose 
signaling is triggered by pain upon heat or mechanical stimulation. Therefore, TMEM16A 
channels play a protective role in inflammatory responses. 
TMEM16A is also protective against inflammatory airway diseases. In tracheal and 
bronchial epithelia, TMEM16A supports the Cl- secretion necessary for basal mucosal regulation 
(Figure 1-1C) [22]. In the absence of TMEM16A in such epithelial cells, mucous secretion is 
reduced [23]. Insufficient amounts of mucous leads to inflammatory airway diseases such as 
asthma and cystic fibrosis [24]. The mucous layer is maintained by the extracellular fluid or airway 
mucous serum which is a complex constituting mucins and glycoproteins, that kept at optimal 
levels, manage pH, cell permeability and inflammatory mediator response [24]. The levels of this 
extracellular fluid is in turn regulated by TMEM16A-conducted Cl- [24]. When TMEM16A 
channels open, Cl- concentration increases in the extracellular fluid. This increase in extracellular 
Cl- upregulates mucous production and leads to the swelling of the mucous layer (Figure 1-1C). 
When TMEM16A channels close, the extracellular fluid decreases and this leads to a reduction in 
the mucous layer (Figure 1-1C). Interestingly, TMEM16A overexpression results in excessive 
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mucus secretion which can also be obstructive to the airway [25]. The role of TMEM16A in 
physiology described just touches the surface on the importance of TMEM16A.  
TMEM16A regulates other proteins as well such as epidermal growth factor receptor 
(EGFR) [26]. TMEM16A promotes EGFR phosphorylation and activates EGFR signaling 
cascades [27]. The physiological importance for correct TMEM16A function cannot be 
underscored enough given not only its role in debilitating diseases, but its potential for therapy in 
these different diseases. TMEM16A could be a suitable target to treat the diseases associated with 
excessive vasoconstriction or inflammatory airways, however, a complete understanding of 
TMEM16A function and regulation is the first step toward achieving this goal. 
1.2.2 TMEM16A discovery 
TMEM16A like other transmembrane member proteins was identified in the human 
genome project [28]. As suggested by its name, amino acid signatures within its sequence revealed 
that it was likely found in cellular membranes. Unbeknownst at the time, TMEM16A was already 
disease associated and called DOG1 (discovered on gastrointestinal stromal tumors protein 1) [29, 
30], ORAOV2 (oral cancer overexpressed protein 2) [31], and TAOS2 (tumor-amplified and 
overexpressed sequence 2) [32].  
Finally, in 2008, TMEM16A, the protein associated with cancer, was classified. Three 
independent labs characterized TMEM16A as a bone fide Ca2+-activated Cl- channel (CaCC)  
using three independent experimental approaches [33-35]. Notably, for about 20 years prior, 
scientists had known that proteins in some cell types could be activated by  Ca2+ and result in Cl- 
currents [36-39] (Figure 1-2). For example, human bronchial cells had been shown to conduct 
Ca2+- activated Cl- in response to interleukin [40] and Xenopus laevis eggs were also shown to 
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conduct Ca2+- activated Cl- currents in response to fertilization [41, 42]. As such, many sought to 
identify the channel conducting these currents. 
To classify TMEM16A, Caputo et al. (2008) employed a global gene expression analysis 
of membrane proteins that took advantage of interleukin’s ability to induce Ca2+- activated Cl- 
currents in bronchial epithelia cells. Using si-RNA against membrane protein hits, they uncovered 
that TMEM16A was responsible for conducting  Ca2+-activated Cl- currents  in bronchial epithelia 
cells [33]. Another group, Yang et al. (2008) scoured public databases for proteins with unknown 
functions with at least two transmembrane domains and wide tissue expression. TMEM16A fit 
these criteria. Upon identifying TMEM16A, they cloned and expressed mouse retinal TMEM16A 
in human embryonic kidney (HEK)293 cells and observed Ca2+- activated Cl- currents [35]. Lastly, 
Schroeder et al. (2008) applied an expression cloning approach where they injected the X. laevis 
oocyte total cDNA into axolotl oocytes that lack endogenous Ca2+-activated Cl- currents. Once 
they successfully measured Ca2+-activated Cl- currents in axolotl oocytes, they fractioned and 
subsectioned the X. laevis oocyte total cDNA until they identified the subsection that resulted in 
Ca2+- activated Cl- currents and then searched the public databases for the identity of TMEM16A 
[34]. Interestingly, in earlier studies TMEM16A was initially referred to as anoctamin 1 for being 
an anion channel predicted to have eight transmembrane domains [35]. Later studies would then 
return to calling it TMEM16A based on its classification as a transmembrane member protein of 
unknown function from the human genome project [43]. 
1.2.3 TMEM16A structure-function 
TMEM16A is presently described as a homodimer made of two subunits each with ten 
transmembrane domains [44-48]. Each subunit acts independently and contains a Cl- conducting 
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pore and two Ca2+ binding pockets [44-47]. Interestingly, the two Ca2+ binding sites are embedded 
in the plasma membrane [44-46]. This unique quality of TMEM16A [45, 46] and some TMEM16 
family members [44] is perhaps linked to its gating properties. When Ca2+ binds TMEM16A, this 
induces a conformational rearrangement that enables the Cl- pore to open and allow Cl-  to pass 
through. Each Ca2+-binding site in the TMEM16A channel can accommodate two Ca2+ and it 
appears as though the channel gates differently depending on whether one or two Ca2+ are bound 
[44-46]. 
The structure of TMEM16A is unlike other CaCCs such as bestrophin 1 (BEST1) (Figure 
1-3). The Ca2+ binding sites of TMEM16A formed by amino acid E698, E701, E702 and E705 
(mTMEM16A a, c and abc splice variants) are embedded in the plasma membrane [49, 50]. On 
the other hand, BEST1’s Ca2+ binding sites formed by amino acids E300, D302 and D303 are 
located on the intracellular side where they form a Ca2+ clasp [51]. Additionally, TMEM16A 
structures have no identifiable pore, but BEST1 has a visible pore shown in the bottom-up view 
(Figure 1-3). Despite more than a decade of intensive studies, we are still uncovering the unique 
structure-function relationship of TMEM16A. 
1.3 TMEM16A regulation  
1.3.1 Ion channel regulation 
In just a blink of an eye, the body must redirect most of a person’s blood to the heart and 
vital organs for a fight or flight response ignited by a threat. TMEM16A channels must  then cause 
vasoconstriction to force blood to vital organs following adrenaline release [17]. With such an 
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important role and many others unmentioned, a major question that arises is how TMEM16A 
channels know when it is appropriate to open and close to match our physiological needs. 
Therefore, I ask how is TMEM16A regulated? Remembering that excessive constriction is 
associated with hypertension, TMEM16A must have regulatory mechanisms in place. Even though 
it is known that TMEM16A is activated by Ca2+, I am interested in determining how TMEM16A 
is regulated in the hope of targeting TMEM16A for therapy in conditions where TMEM16A is 
associated with disease.  
Cells employ several mechanisms to regulate ion channels and therefore, their excitability. 
Ion channels can be regulated by ligand-binding, pressure changes, voltage fluxes, cellular volume 
changes, post-translational modifications, pH changes, protein interactions, protein degradation 
and fatty acid interactions [4]. The importance of each of these mechanisms to a channel’s 
regulation depends on the physiological role of the channel. For example, the ligand gated ion 
channel gamma-aminobutyric acid type A (GABAA) requires the binding of the neurotransmitter 
GABA which binds an extracellular loop on the channel and activates GABAA so that Cl- flows 
into the cell and hyperpolarizes the neuron membrane [52] during a process such as learning [4]. 
This hyperpolarization inhibits glutamate signaling in the central nervous system (CNS) [52]. 
Tightly regulated GABAA activity is required to enable correct CNS function. On the other hand, 
the K+ voltage gated inwardly rectifying ion channels (Kir1-7) are gated by the inner membrane 
abundant fatty acid phosphatidylinositol 4,5-bisphoshate (PI(4,5)P2), and depending on the Kir 
subfamily, the Kirs are either constitutively active, G protein-gated, ATP-sensitive or cellular 
metabolism-sensitive [53]. Once activated by changes in voltage, Kir channels allow K+ into the 
cell to repolarize cell membranes. A tight regulation of Kir is required to enable correct function 
in in the CNS, muscular system and neuromuscular system [54]. 
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Kir channels and GABAA are just a few of the 285 known ion channels of the human 
genome whose mechanisms have been studied [55]. Learning how such ion channels are regulated 
has been instrumental in drug design. For example, by knowing that K+ regulates the kidney’s 
electrolyte and water balance, and influences blood pressure, a drug and a small molecule inhibitor 
(MK-7145) was designed to block Kir1.1. MK-7145 treats hypertension and heart failure [56, 57] 
but manifests symptoms of Bartter’s syndrome [58]. Bartter’s syndrome is an inheritable disease 
caused by a defect in the loop of Henle’s thick ascending limb that causes hypokalemia or low 
potassium levels [58]. An ideal drug would not manifest Barrter’s syndrome. Thus, it is important 
to understand the fine details of an ion channel’s regulation. My goal is to characterize the 
signaling mechanisms regulating TMEM16A channels. Elucidating the regulatory mechanisms 
gating TMEM16A could result in effective therapeutic drugs for TMEM16A associated diseases 
and those of similar TMEM16 family whose regulation will be discussed next. 
1.3.2 TMEM16 family regulation 
The mammalian TMEM16 family is composed of the ten members TMEM16A-K 
(excluding I) that share 37 to 77% sequence similarity to TMEM16A [59]. The regulation of 
TMEM16C-K excluding TMEM16F are poorly understood. TMEM16C, TMEM16D, TMEM16G 
and TMEM16K are phosphatidylserine scramblases lacking Ca2+-evoked Cl- currents [60]. 
TMEM16E, also known as GDD1 for its role in the bone‐related late‐onset disease 
gnathodiaphyseal dysplasia (GDD), does not conduct Ca2+-evoked Cl- currents nor does it show 
phosphatidylserine scramblase activity [61]. This might be due to TMEM16E’s inability to traffic 
to the plasma membrane [61]. Similarly, TMEM16J does not localize to the plasma membrane and 
is instead located at plasma membrane-endoplasmic reticulum (ER) junctions where it acts as a 
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tether allowing for the ER Ca2+ sensor STIM1 and the plasma membrane Ca2+ influx channel Orai1 
to form complexes at PI(4,5)P2‐rich compartments [62]. 
 TMEM16B and TMEM16F conduct ions at the plasma membrane. TMEM16B is the most 
similar to TMEM16A (Figure 1-4). Not only does it have the highest sequence similarity (77%), 
it is also a CaCC [63-66]. Thus, TMEM16B is activated by Ca2+ to enable the passage of Cl- 
through its pore. It is expressed at the plasma membranes of retinal photoreceptors and olfactory 
sensory neurons [64, 66]. To date, studies determining how TMEM16B is gated have suggested 
that in addition to Ca2+, TMEM16B gating is modulated by permeant anions and phosphatidyl 4,5-
bisphosphate (PI(4,5)P2) [67, 68]. The bigger and more permeant anion thiocyanate requires a 
lower concentration of  Ca2+ to pass through TMEM16B channels than Cl- does [67, 68]. The other 
component regulating TMEM16B gating, PI(4,5)P2, is a minor component at the plasma 
membrane and  its water soluble analogue (diC8-PI(4,5)P2) was shown to inhibit TMEM16B Ca2+-
evoked Cl- currents when applied to TMEM16B channels expressed in HEK293 cells [68]. 
Conversely, depletion of PI(4,5)P2 via the activation of the Danio rerio voltage sensing 
phosphatase (Dr-VSP) resulted in greater TMEM16B Ca2+-evoked Cl- currents [68]. 
TMEM16F is quite different from TMEM16A both in sequence and in activity (Figure 1-
4 and Figure 1-5). Although our initial understanding of TMEM16A was based on the fungus 
Nectria haematococca TMEM16 (nhTMEM16) scramblase which was the first crystal structure 
purified for this family of proteins [44], TMEM16A and TMEM16F only share 56% sequence 
similarity. Nevertheless, from nhTMEM16, we learned that TMEM16A and other TMEM16 
proteins share similar structure and have Ca2+ binding sites located in the plasma membrane [44]. 
Consistently, mutating TMEM16A Ca2+ binding sites based on nhTMEM16 Ca2+ binding sites 
reduced TMEM16A Ca2+ sensitivity [44]. Additionally, TMEM16F also conducts ions although 
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whether it is a cation or anion conducting channel remains controversial. However, all agree that 
TMEM16F’s scramblase and ion conduction are Ca2+-dependent [69-72]. TMEM16F gating is 
also regulated by PI(4,5)P2 which is believed to interact with the residues involved in scrambling 
[73]. In contrast to TMEM16B, diC8-PI(4,5)P2 potentiates TMEM16F currents and the depletion 
of PI(4,5)P2 was shown to reduce TMEM16F Ca2+-evoked currents [73]. 
1.3.3 TMEM16A gating 
Using a combination of structural and regulatory information from the TMEM16 family, 
we have begun to understand how TMEM16A channel activity is finely tuned. Based on the 
similarities TMEM16A shares with TMEM16B and TMEM16F, it is possible TMEM16A binds 
PI(4,5)P2 similarly to TMEM16B and TMEM16F. Previous studies suggest that TMEM16A 
gating is influenced by alternative splicing [74], volume [74, 75], acid [76], cholesterol [77, 78], 
heat [79], and phosphoinositides [80-83]. My aim was to characterize physiologically relevant 
modulators of TMEM16A. Taken together, previous studies indicate that Ca2+ is necessary to 
evoke TMEM16A-conducted Cl- currents. However, Ca2+ is a widely utilized signaling molecule 
involved in diverse signaling cascades separate from TMEM16A. This puts into question how 
TMEM16A channels are regulated to ensure that they are only activated when needed. Therefore, 
I sought to determine the signaling mechanisms that alter TMEM16A gating. To address my aims, 
I used the endogenous Xenopus laevis TMEM16A channels to study its regulation. 
TMEM16A structures have provided important clues about TMEM16A gating. Firstly, 
cryogenic electron microscopy (Cryo-EM) findings supported the general architecture of 
TMEM16A extrapolated from the nhTMEM16 crystal structure suggesting that indeed it is much 
like the nhTMEM16 scramblase but contains differences in the ion pore [7]. Second, Cryo-EM 
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focused on the ion conduction pore revealed the unique coupling of Ca2+ binding to pore opening 
[46]. Bound Ca2+ alters the electrostatic properties of the pore conduction pathway by triggering a 
rearrangement of a-helix six or transmembrane 6 (TM6) [46]. Thirdly, nanodiscs obtained via 
single-particle electron cryo-microscopy revealed that not only is each monomer capable of 
binding two Ca2+, but that in this state, the TMEM16A pore is closed [45], hinting that an 
additional component is required to open the Cl- pore.  
Functional studies have also provided important clues for TMEM16A gating. First, 
recordings of the Ca2+-evoked Cl- currents under conditions distinguishing each subunit of the 
dimer suggest that TMEM16A subunits activate independently of each other [47]. Mutations 
inhibiting an individual pore in one subunit did not reduce the conduction of the second subunit’s 
Cl- pore suggesting that the Cl- pores also open independently of each other [48]. Second, 
TMEM16A gating properties dependent on Ca2+, anion type and voltage are conferred by the a-
helix on TM6 [71]. This is explained by the idea that some residues contributing to the putative 
Cl- pore and Ca2+-binding site are located on TM6. Lastly, TMEM16A occupies different 
conformational states based on whether one or two Ca2+ bind each subunit  (Figure 1-6) [44-46]. 
Taken together, these functional studies report that TMEM16A gating is regulated by Ca2+ whose 
occupancy on the dimer is required to open its pores. However, structural studies with complete 
Ca2+ occupancy reveal that TMEM16A channels are closed which gives rise to the hypothesis that 
additional cellular components, perhaps similar to those regulating TMEM16B and TMEM16F 
gating, are required to open TMEM16A. 
1.4 Xenopus laevis oocytes as a model for TMEM16A studies 
Oocytes from the African clawed frog, Xenopus laevis, are a classic model cell 
for electrophysiologists. The oocytes, arrested in prophase I,  are an excellent expression system 
that has been used by biophysicists to study ion channel function and regulation for decades 
[83-86].  
The primary strength of the X. laevis oocytes for the purpose of my studies is that 
TMEM16A is endogenously and abundantly expressed in these cells [34]. Additionally, these 
oocytes provide a native environment to identify how TMEM16A gating is regulated. Notably, 
previous studies investigating TMEM16A regulation in exogenous systems have resulted in 
conflicting findings [81, 87]. 
Other benefits of the X. laevis model that make using them ideal for ion channel studies 
are as follows: 1) thousands of oocytes can be obtained surgically, 2) these oocytes are large 
(1.2-1.3 mm in diameter), and 3) they can easily be injected with cRNA to exogenously 
express desired proteins [88, 89]. In summary, X. laevis oocytes have been instrumental in the 
study of diverse ion channels and are one of the model cells used in the classification of 
TMEM16A as a CaCC.  
1.5 Dissertation aims 
Although TMEM16A was classified as a CaCC in 2008 and structures have been 
resolved revealing information about the channel, TMEM16A’s regulation has remained 
unclear. In particular, the components necessary for the channel to open are only beginning to 
be understood. Two aims of my dissertation were to uncover the signaling mechanism 
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mediating TMEM16A gating including: 1) the PI(4,5)P2 regulation of TMEM16A, and 2) the 
multimodal Ca2+ regulation of TMEM16A. The first of these aims was published in the Journal 
of Biological Chemistry and is described in chapter 3 [90]. The second of these aims will be 
submitted for publication also to Journal of Biological Chemistry and is described in chapter 4. 
1.6 Figures 
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 Figure 1-1. TMEM16A's role in physiology 
TMEM16A is expressed in multiple cell types including A) smooth muscle, B) dorsal root ganglion (DRG) neurons 
and C) airway epithelial. A) In smooth mucle cells, TMEM16A channels open to constrict vessels and close to dilate 
them. B) In DRG neurons, TMEM16A channels open and result in the membrane depolarizing (firing) or becoming 
more postively charged following a stimulatory signal such as pain. C) In airway epithelial cells, the airway is kept 
moist by fluid that regulates the mucousal layer. Opening TMEM16A channels dispenses Cl- into the fluid cavity and 
this causes water to flow into the cavity and increase fluid. This increase in fluid is necessary to maintain healthy and 
protective mucous levels. 
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Figure 1-2. Schematic depicting the activation of a Ca2+-activated Cl- channel (CaCC) 
CaCCs are embedded in the plasma membrane. (A) In the absence of Ca2+, CaCCs remain closed and the membrane 
potential is negative. (B) Upon an increase in intracellular Ca2+, Ca2+ binds the CaCC Ca2+ binding sites, enabling the 
Cl- pore to open. The open pore then allows the passage of Cl- and results in the membrane depolarizing. 
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Figure 1-3. Homology model of mouse TMEM16A and structure of chicken Bestrophin 1 
 (A) TMEM16A (PDB:5OYB) consists of two identical subunits embedded in the membrane indictated by the lines. 
Each TMEM16A subunit has ten transmembrane domains, and an ion conduction pore which to date has not been 
resolved clearly. Notably, each subunit has two Ca2+ binding sites embedded in the membrane. (B) Bestrophin 1 
(BEST1) (PDB: 6N25) is made of five identical subunits spanning the membrane four times each. The subunits are 
arranged to form a central ion conduction pore which opens when Ca2+ binds its intracellular sites found on each 
subunit. BEST1’s Ca2+ binding sites are not embedded in the membrane like TMEM16A’s but are instead found on 
the intracellular side of the cell. Red spheres represent Ca2+. 
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Figure 1-4. Human TMEM16 family phylogenetic tree 
TMEM16A is just one of ten proteins in the TMEM16 family predicted to be ion channels or scramblases. TMEM16A 
is most closely related and similar to TMEM16B (blue) (77%). Colored grey are the family members whose functions 
remain to be understood. Although TMEM16F (orange) is not the most similar to TMEM16A (56%), its structural 
information has been instrumental in learning about TMEM16A. Percentages show similarity to TMEM16A. Blue 
shows CaCCs. Red shows channel/scramblase. The phylogenetic tree was generated using software : Dendroscope  
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Figure 1-5. Homology model of mouse TMEM16A aligned with Nectria haematococca TMEM16 
The scramblase nhTMEM16 (PDB: 6QM5) crystal structure (orange) was obtained in 2014. nhTMEM16 aligns 
closely with mouse mTMEM16A (magenta) and has been used to provide information about TMEM16A as previously 
discussed. Like TMEM16A, nhTMEM16 can bind four Ca2+ in similar regions as TMEM16A. However, some 
differences in structural arrangement can be seen as depicted in the bottom-up view or intracellular side (right). 
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Figure 1-6. Schematic depicting TMEM16A gating 
TMEM16A gating depends on the presence of Ca2+  and voltage. At low concentrations of Ca2+ where not all Ca2+ 
binding sites are occupied, TMEM16A channels can allow Cl- passage in a voltage dependent manner. At high 
concentrations of Ca2+ where most Ca2+ binding sites are occupied, TMEM16A Cl- conductance does not depend on 
voltage and allows continuous Cl-  passage. 
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2.0 Materials and Methods  
2.1 Reagents 
Dioctanoyl phosphatidylinositol (diC8-PI), dioctanoyl 3-monophosphate diC8-PI(3)P, 
dioctanoyl 4-monophosphate diC8-PI(4)P, dioctanoyl 5-monophosphate diC8-PI(5)P, dioctanoyl 
phosphatidylinositol 3,4-bisphosphate (diC8-PI(3,4)P2), dioctanoyl phosphatidylinositol 4,5-
bisphosphate (diC8-PI(4,5)P2), dioctanoyl phosphatidylinositol 3,5-bisphosphate (diC8-
PI(3,5)P2), dioctanoyl phosphatidylinositol 3,4,5-trisphosphate (diC8-PIP3) and anti-
phosphatidylinositol 4,5-bisphosphate IgM (anti-PI(4,5)P2: Echelon Cat#:Z-P045, Lot#: 080416) 
were obtained from Echelon Biosciences. MgCl2, CaCl2 and NiCl2 were purchased from Sigma-
Aldrich. U-73343 and U-73122 were purchased from Tocris. Unless otherwise noted, all other 
reagents were purchased from Thermo Fisher Scientific. 
2.2 Solutions 
2.2.1 Oocyte wash and storage solution 
Oocyte wash and storage solution were made as follows: Oocyte Ringers 2 (OR2) (in mM): 
82.5 NaCl, 2.5 KCl, 1 MgCl2, and 5 mM HEPES, pH 7.2. ND96 (in mM): supplemented with 5 
mM sodium pyruvate and 100 mg/L gentamycin, pH 7.6 and filtered with a sterile, 0.2 μm 
polystyrene filter [92]. 
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2.2.2 Inside-out patch clamp solutions 
All excised inside-out patch clamp recordings were made in HEPES-buffered saline 
solution (in mM): 130 NaCl and 3 HEPES, pH 7.2, and filtered using a sterile, 0.2 μm polystyrene 
filter. For Ca2+-free recordings, this solution was supplemented with 200 μM EGTA. For solutions 
used during Ca2+ application, the HEPES-buffered saline solution was supplemented with 100 µM 
or 500 µM or 2 mM CaCl2. Where indicated 2 mM CaCl2 was substituted with 2 mM NiCl2 or 
MgCl2.  
2.3 Animals 
Animal procedures were conducted using accepted standards of humane animal care and 
approved by the Animal Care and Use Committee at the University of Pittsburgh. X. laevis adult, 
oocyte-positive females were obtained commercially (RRID: NXR_0.0031, NASCO, Fort 
Atkinson, WI) and housed at 18 °C with 12/12-hour light/dark cycle. Oocytes were collected from 
X. laevis females anesthetized by immersion in 1.0 g/L tricaine pH 7.4, for 30 minutes. Ovarian 
sacs containing the oocytes were surgically removed from the female, manually pulled apart, and 
incubated for 90 minutes in 1 mg/ml collagenase diluted in ND96 solution. Collagenase was 
removed by several OR2 rinses, and healthy oocytes were stored at 14°C in ND96 for up to 14 
days. 
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2.4 Experimental methods 
2.4.1 Inside-out patch clamp 
Patch clamp recordings were made on X. laevis oocytes following the manual removal of 
the vitelline membrane. Current recordings were made in the excised inside-out configuration of 
the patch clamp technique with an EPC-10 USB patch clamp amplifier (HEKA Elektronic) [93]. 
Briefly, after formation of a gigaseal (greater than 1 GW) on the oocyte membrane, inside-out 
patches were excised in HEPES-buffered saline solution without EGTA (where resistances 
decreased to 10-200 MW in solutions lacking EGTA but returned to at least 1 GW with EGTA 
application). Data were collected at a rate of 10 kHz. Glass pipettes were pulled from borosilicate 
glass (OD 1.5 mm, ID 0.86 mm; Warner Instruments), fire polished (Narshige microforge), and 
had a resistance of 0.4-1.5 MΩ. Lipids were applied to excised inside-out patches in a RC-28 
chamber (Warner Instruments). All other solutions were applied using a VC-8 fast perfusion 
system (Warner Instruments). All inside-out patch recordings were initiated within 10 s of patch 
excision. 
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2.5 Quantification and statistical analysis 
2.5.1 Inside-out patch data analysis 
Currents recorded in the inside-out patch configuration were normalized for analysis such 
that peak currents recorded in Ca2+ (or Ni2+) were equated to 1 and basal currents recorded in Ca2+-
or divalent-free conditions were equated to 0.  
Controls are plotted with dashed lines and represent an idealized averaged normalized 
current versus time calculated using the single exponential equation: 
Y (x) = Y0 ´ e!"t  
where Y(x), Y0, x, and t represent the current at time x, initial current, time, and rate of current 
rundown, respectively. Briefly, current traces were collected and fitted with the single exponential 
equation above to derive the Y0, x, and t per trace. For the Ca2+ control and otherwise indicated 
control conditions, averaged plots of current rundown were plotted along with the normalized 
current versus time graphs and depicted as the predicted current traces displayed as dashed lines.  
Analyzed kinetics data are displayed in Tukey box plot distributions where the box depicts 
25-75% of the data range, the central line represents the median value and the whiskers span 10-
90%. Additionally, to simplify comparison between the kinetics of current rundown recorded 
under experimental conditions to controls, the normalized current for each condition is plotted 
together with the averaged rundown for associated control either the 2 mM Ca2+ or the indicated 
control. 
To compare the magnitude of current recovered using the synthetic lipid analogs the fold 
change in current recovered was calculated by dividing the peak current after lipid addition by 
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baseline current. The peak current was defined as the maximum current recorded after lipid 
addition and the baseline current was defined as the steady-state current observed at the time of 
lipid addition. The equation used was: 
Current recovered = #$%&#'#	)'**+,-	$.-+*	/&0&1	$11&-&2,3$4+/&,+	)'**+,-	$-	/&0&1	$11&-&2,  
The baseline current was normalized to 1. All experiments include trials conducted on 
multiple days with oocytes collected from different females.  
Two-tailed ANOVAs were used to assess differences between experiment conditions, 
followed by post-hoc t-tests to evaluate differences between particular experimental treatments. 
2.6 Figures 
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Figure 2-1. Inside-out patch clamp technique 
Schematic of recordings made in the inside-out patch clamp configuration. A Xenopus laevis oocyte is placed in a 
bath solution lacking Ca2+. Two electrodes are also placed in the bath solution; one is a reference electrode and 
completes the circuit and the other is attached to a glass pipette for current recording. The glass pipette is placed on 
the oocyte membrane and suction is applied to pull a patch of membrane and form a GW seal, an indication that the 
pipette and the membrane are continuous. After formation of a seal, the pipette is slowly moved away from the oocyte 
to expose the membrane’s intracellular side to the bath solution [94]. Next, the patch is placed at the rapid perfusion 
chamber where different solutions are applied while Cl- passage (current) through the patch is recorded.  
0 Ca2+
2 mM Ca2+ with 
Mg-ATP
2 mM Ca2+
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3.0 TMEM16A Gating is Regulated by PI(4,5)P2 
This chapter is an adaptation of  the published article: © 2019 Tembo et al. [92] published 
the Journal of Biological Chemistry https://doi.org/10.1074/jbc.RA118.007128 
3.1 Introduction 
TMEM16A is essential for diverse physiological processes such as smooth muscle 
contraction [95-97] and signal transduction [98, 99]. Disrupting TMEM16A function has serious 
implications exemplified by the perinatal lethality phenotype in TMEM16A-null mice [100]. Yet, 
how TMEM16A is functionally regulated is not well understood. As a key mediator in multiple 
physiological processes, this channel could be a target for novel therapeutics to treat chronic 
conditions such as hypertension. 
Determining how TMEM16A controls physiological processes requires a more nuanced 
understanding of how cellular events and second messengers alter TMEM16A channel gating. To 
date, TMEM16A is known to be activated by elevated intracellular Ca2+ which binds to a 
membrane-embedded domain located near a Cl- conducting pore [33-35, 45-48, 101]. The binding 
of Ca2+ to its cognate domain on TMEM16A induces a conformational rearrangement of the α-
helix on TM6 that physically opens the anion conducting pore [46]. Each Ca2+-binding site on the 
TMEM16A channel can accommodate two Ca2+ cations, and it appears as though the channel gates 
differently depending on whether one or two cations are bound [47, 48, 71]. Intriguingly, the recent 
cryo-EM structures of TMEM16A in a Ca2+-bound state revealed that the anion pore was not wide 
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enough for Cl- permeation suggesting that Ca2+ alone is not sufficient to activate TMEM16A 
channels [45, 46]. Another signaling molecule that may regulate TMEM16A is the acidic 
phospholipid phosphatidyl 4,5-bisphosphate (PI(4,5)P2) [68, 71, 78, 81].  
PI(4,5)P2 is a minor component of the membrane (Figure 3-1), yet it is a master regulator 
of membrane function [102]. Importantly, PI(4,5)P2 serves as the substrate for phospholipase C 
(PLC) cleavage to produce inositol triphosphate (IP3) and diacylglycerol (DAG); pathways that 
transduce extracellular signals to intracellular signaling events. However, PI(4,5)P2 also serves as 
a signaling molecule in its own right by regulating endocytosis and exocytosis, actin 
polymerization, establishment of basolateral polarity, and regulation of ion channels [103]. A 
possible role for PI(4,5)P2 in TMEM16A regulation has already been explored by other groups, 
however, the interpretation of how PI(4,5)P2 alters TMEM16A currents remains disputed: one 
study reported that PI(4,5)P2 inhibits TMEM16A [75], another states that it does not regulate the 
channel  [98], and yet two others indicate that PI(4,5)P2 promotes TMEM16A activity [68, 78, 81, 
104]. I speculate that the disparity between the experimental interpretations may stem from the use 
of indirect methods.  
The objective of this research was to determine whether the phospholipid PI(4,5)P2 
regulates TMEM16A channels. For these experiments, I made electrophysiology recordings from 
Xenopus laevis oocytes, cells that endogenously and abundantly express TMEM16A channels 
[34]. Using excised inside-out patch clamp together with methods that directly alter the available 
PI(4,5)P2 content of the patch, I found that TMEM16A currents decayed following patch excision. 
By changing the available PI(4,5)P2 content, I altered the kinetics of this rundown. Moreover, 
depleting the membrane PI(4,5)P2 rendered TMEM16A channels unable to conduct current even 
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in saturating concentrations of intracellular Ca2+. Together these findings establish that 
TMEM16A channels are potentiated by PI(4,5)P2. 
3.2 Results 
3.2.1 TMEM16A currents recorded from excised inside-out patches decay 
To study TMEM16A currents, I made recordings of the endogenous channel in X. laevis 
oocytes using the inside-out configuration of the patch clamp technique. Notably, the prominent 
Ca2+-activated current recorded from these cells is conducted by TMEM16A channels [34]. During 
100-150 ms steps to -60 and +60 mV, I observed robust, Ca2+-activated TMEM16A currents at 
both voltages (Figure 3-2A). Surprisingly, these currents decayed over time despite the continued 
presence of a saturating concentration of intracellular Ca2+ [45]. Figure 3-2A depicts typical 
currents recorded at -60 and +60 mV, at 30, 60, 120, and 180 s following 2 mM Ca2+ application. 
Loss of current from excised patches is a phenomenon known as rundown [105]. This can be 
observed also in Figure 3-2B depicting typical currents normalized to the highest currents recorded 
at -60 and +60 mV over time. I next sought to characterize the rundown of TMEM16A-conducted 
currents after patch excision.  
I first explored whether the rundown of TMEM16A currents was voltage dependent. To do 
so, plots of the currents recorded during steps to -60 mV or +60 mV, versus time, were fit with 
single exponential functions, and enabled me to quantify the kinetics of rundown (Equation 1) 
(Figure 3-2C).  In 15 independent experimental trials, the average rate of rundown was 68.9 ± 7.1 
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s at -60 mV, and 63.8 ± 5.9 s at +60 mV (Table 3-1 and Figure 3-2D). Similar kinetics measured 
at the two voltages reveal that the current decay is voltage independent.  
To explore a possible relationship between the rate of rundown and the number of channels 
in an excised patch, I plotted the rate of current decay recorded at -60 mV versus the peak steady 
state current (Figure 3-3). In 15 independent trials, I found that there was no apparent relationship 
between these two metrics. These data represent a negative control suggesting that TMEM16A 
currents ran down regardless of pipette size or the number of channels opened by Ca2+ across the 
different trials. 
3.2.2 PI(4,5)P2 recovered TMEM16A currents in inside-out excised patches 
Rundown of currents recorded in the inside-out configuration of the patch clamp technique 
is characteristic of channels regulated by PI(4,5)P2 [103]. I therefore hypothesized that if 
TMEM16A current rundown occurred due to the depletion of PI(4,5)P2 in excised patches, 
exogenous PI(4,5)P2 application should recover TMEM16A currents following their decay. To test 
this hypothesis, I applied a water-soluble analog of PI(4,5)P2 [106-109], dioctanoyl-PI(4,5)P2 
(diC8-PI(4,5)P2), to inside-out patches excised from X. laevis oocytes (Figure 3-4A). For these 
experiments, I recorded TMEM16A-conducted currents at -60 mV before and during the 
application of 2 mM Ca2+. Once the Ca2+-activated currents ran down to a steady state, I applied 
100 µM diC8-PI(4,5)P2 [68] in the presence of 2 mM Ca2+. Figure 3-4B depicts an example plot 
of TMEM16A-conducted currents recorded at -60 mV versus time, before and during 100 µM 
diC8-PI(4,5)P2 application in the presence of Ca2+. In seven independent trials, I observed that 100 
µM diC8-PI(4,5)P2 application recovered an average 38% of the peak current. Because I did not 
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observe full TMEM16A current recovery with 100 µM diC8-PI(4,5)P2, I explored whether this 
was due to the short fatty acid tail or the concentration of diC8-PI(4,5)P2 applied. I first conducted 
a similar experiment where I applied 100 µM natural PI(4,5)P2 (Figure 3-4C and D). Surprisingly, 
I observed that natural PI(4,5)P2 recovered an average of 23% of the peak current, which was less 
than the current recovered by 100 µM diC8-PI(4,5)P2. I proceeded with further experimentation 
only using the diC8-PI(4,5)P2. Next, I sought to estimate the concentration-response for diC8-
PI(4,5)P2. I conducted additional TMEM16A current recovery experiments using 10 µM diC8-
PI(4,5)P2 (Figure 3-4E) and 30 µM diC8-PI(4,5)P2 (Figure 3-4F). I observed that 10 µM or 30 µM 
diC8-PI(4,5)P2 incompletely recovered the current compared to 100 µM diC8-PI(4,5)P2 (Figure 3-
4G). Altogether, the data suggest that PI(4,5)P2 recovers TMEM16A currents and that the currents 
are recovered in a concentration-dependent manner.  
After demonstrating that PI(4,5)P2 recovers TMEM16A currents, I sought to further 
characterize the relationship between PI(4,5)P2 and TMEM16A. I tested whether 100 µM diC8-
PI(4,5)P2 (Figure 3-5A) was sufficient to recover TMEM16A current following rundown, or if 
diC8-PI(4,5)P2 and Ca2+ were both required. Application of diC8-PI(4,5)P2 in the absence of Ca2+ 
had a nominal effect on TMEM16A, with a recovery of 1.1 ± 0.1-fold (N= 5, Figure 3-5B and C). 
These data demonstrate that although Ca2+ activates TMEM16A, PI(4,5)P2 is required for these 
channels to conduct Cl- currents. Moreover, PI(4,5)P2 potentiates TMEM16A currents only in the 
presence of intracellular Ca2+. 
The diC8-PI(4,5)P2 compound could theoretically regulate TMEM16A channels by 
interactions mediated by its lipid tail group or its phosphoinositol head group (Figure 3-1). Thus, 
I tested the hypothesis that the dioctanoyl-phosphoinositol (diC8-PI) backbone (Figure 3-5A) 
alone was sufficient to recover current. Following TMEM16A current rundown, I applied 100 µM 
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diC8-PI with Ca2+ and quantified the proportion of current recovered. Figure 3-5D shows an 
example plot of TMEM16A currents recorded at -60 mV versus time, before and during diC8-PI 
application. In six separate trials, I observed that 100 µM diC8-PI application nominally altered 
the TMEM16A currents, recovering 1.4 ± 0.2-fold current, which was significantly lower than the 
3.6 ± 0.5-fold current recovered by diC8-PI(4,5)P2 with Ca2+, but not significantly different from 
the current recovered by diC8-PI(4,5)P2 in the absence of Ca2+ (Figure 3-5B). This result 
demonstrates that without the phosphorylated head groups, diC8-PI was unable to recover 
TMEM16A currents, thereby suggesting that the phosphates on the inositol head-group mediate 
the TMEM16A-PI(4,5)P2 interaction.  
3.2.3 Scavenging PI(4,5)P2 sped TMEM16A current rundown    
My finding that diC8-PI(4,5)P2 restored TMEM16A currents following rundown suggested 
that rundown may be the result of PI(4,5)P2 depletion in excised patches. Thus, I reasoned that I 
should be able to speed rundown by applying compounds that compete with TMEM16A for 
binding to PI(4,5)P2. I tested this hypothesis by quantifying the rate of TMEM16A current decay 
during application of two compounds known to scavenge PI(4,5)P2: a PI(4,5)P2-targeting antibody 
(anti-PI(4,5)P2) [110] or neomycin [111, 112] (Figure 3-6A). I began these experiments by 
recording TMEM16A currents at -60 mV before and during treatment with 2 mM Ca2+ applied 
with 15 μg/ml anti-PI(4,5)P2. In four independent trials, I observed that TMEM16A current ran 
down with an average rate of 48.6 ± 7.4 s in the presence of anti-PI(4,5)P2 compared to 68.9 ± 7.3 
s from patches treated with 2 mM Ca2+ alone (N = 15) (Figure 3-6B and C, Table 3-1).  
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In a parallel series of experiments, I quantified the rate of TMEM16A current rundown in 
the presence of the PI(4,5)P2 scavenger neomycin. Neomycin is an antibiotic that also scavenges 
PI(4,5)P2 when applied to the intracellular membrane at high concentrations [111]. Figure 3-5D 
depicts an example plot of the TMEM16A currents recorded at -60 mV versus time, before and 
during 2 mM Ca2+ and 50 mM neomycin application. In five independent trials, neomycin sped 
current rundown from 68.9 ± 7.3 s to 32.0 ± 8.8 s (Figure 3-6B).  
Altogether, I observed that both anti-PI(4,5)P2 and neomycin application sped TMEM16A 
rundown (Figure 3-6). Moreover, the rate of rundown was not significantly different in the 
presence of either anti-PI(4,5)P2 or neomycin (Figure 3-6B and Table 3-1) consistent with the 
hypothesis that each compound was acting by scavenging PI(4,5)P2 rather than exerting 
nonspecific effects on the channel. Together, these data support the hypothesis that PI(4,5)P2 is 
required for TMEM16A to conduct Cl- currents.  
3.2.4 Slowing PI(4,5)P2 depletion slowed TMEM16A rundown  
Phosphatases and kinases work together to maintain stable levels of PI(4,5)P2 in whole 
cells (Figure 3-7A) [102]. In excised patches, however, membrane-anchored kinases lack access 
to the ATP required to fuel phosphorylation and regeneration of PI(4,5)P2 [102, 103]. 
Consequently, continued activity of phosphatases without counter-acting kinases leads to PI(4,5)P2 
dephosphorylation. I reasoned that if TMEM16A currents decayed in excised patches due to the 
dephosphorylation of PI(4,5)P2, then enabling rephosphorylation or inhibiting phosphatases 
should slow current loss. I tested the hypothesis by determining whether enabling 
rephosphorylation of PI(4,5)P2 with application of magnesium-adenosine triphosphate (Mg-ATP) 
[113, 114] would slow TMEM16A current rundown in excised inside-out patches. As a control for 
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these experiments, I first recorded TMEM16A currents at -60 mV before and during the 
application of magnesium adenosine monophosphate (Mg-AMP), which can bind to, but not 
activate, kinases. Thus, Mg-AMP application should not affect current rundown. Indeed, I 
observed no difference in current rundown between Mg-AMP and control condition of 2 mM Ca2+ 
(Figure 3-7B and 3-7C). I then recorded TMEM16A currents at -60 mV before and during 
application of 2 mM Ca2+ with 1.5 mM Mg-ATP. An example plot of normalized current versus 
time is shown in Figure 3-7D. I observed that in the presence of 1.5 mM Mg-ATP and 2 mM Ca2+, 
TMEM16A currents ran down over a longer time course, with a time constant of 143.4 s ± 17.2s 
(N=5) (Fig 3-7D and Table 3-1).  
Next, I reasoned that if phosphatase-mediated PI(4,5)P2 depletion causes TMEM16A 
current rundown in excised patches then inhibiting phosphatase activity would also slow rundown. 
I tested this hypothesis by quantifying the kinetics of current rundown in the presence of Ca2+ and 
the general phosphatase inhibitor sodium b-glycerophosphate pentahydrate (bGP) [115]. Figure 
3-7E depicts an example plot of TMEM16A-conducted currents recorded at -60 mV versus time, 
before and during application of 50 mM bGP and 2 mM Ca2+. In five independent trials, I observed 
that TMEM16A currents ran down slower in the presence of the phosphatase inhibitor, with a time 
constant of 166 s ± 14.7 s (N=5) (Fig 3-7E and Table 3-1). Together, these data suggest that 
TMEM16A currents rundown in excised patches as the result of PI(4,5)P2 depletion via its 
dephosphorylation. Moreover, these data are consistent with the hypothesis that the phosphates 
found on the inositol head group of PI(4,5)P2 are responsible for the interaction between 
TMEM16A and PI(4,5)P2. 
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3.3 Discussion 
By recording TMEM16A currents while modifying the membrane PI(4,5)P2 content, here 
I demonstrate that these channels require both Ca2+ and PI(4,5)P2 to conduct current. A possible 
role for PI(4,5)P2 in TMEM16A regulation was initially suggested by rundown of these currents 
recorded from X. laevis oocytes despite the continued presence of a saturating concentration of 
Ca2+ (Figure 3-2). Rundown results from the removal of a membrane patch from the cytosol that 
includes ATP [102]. This ATP is required to fuel the phospholipid kinases which rephosphorylate 
the phospholipids present in the membrane [102]. As such, current rundown in excised patches is 
a hallmark of channels regulated by PI(4,5)P2. 
3.3.1 PI(4,5)P2 regulates TMEM16A gating 
Application of the soluble PI(4,5)P2 analog, diC8-PI(4,5)P2, recovered TMEM16A 
conducted currents following rundown, but only when applied with Ca2+ (Figure 3-3 and 3-4). Not 
all TMEM16A current was recovered with diC8-PI(4,5)P2 application. 100 µM diC8-PI(4,5)P2 
applied without Ca2+ had a nominal effect on TMEM16A currents revealing that both Ca2+ and 
PI(4,5)P2 are required for the phospholipid to potentiate these channels. I speculate that the 
incomplete recovery with 100 µM diC8-PI(4,5)P2 applied with Ca2+ may reflect a slow rate of 
PI(4,5)P2 integration into the membrane. This is consistent with my observation that the current 
recovery was diminished when longer acyl chains were applied to patches (Figure 3-5). 
Alternatively, the incomplete recovery may reflect the role of a Ca2+ dependent recovery of 
PI(4,5)P2. PI(4,5)P2 recovery can be more pronounced at lower Ca2+ than at higher Ca2+ [68]. This 
complex relationship between PI(4,5)P2 and Ca2+ needs to be explored further in my system.  
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Phospholipid-mediated recovery of TMEM16A currents following rundown requires 
phosphorylation of the inositol ring. Accordingly, I found that 100 µM diC8-PI, the phospholipid 
lacking the negatively charged phosphate head groups, was unable to recover TMEM16A currents 
(Figure 3-5). In contrast to the recent report that suggests that the neutral acyl chain of fatty acids 
is sufficient to regulate TMEM16A [78], my findings suggest that TMEM16A potentiation by 
PI(4,5)P2 requires the presence of phosphate heads which are lacking in lipids like oleic acid or 
cholesterol. My results do not preclude the possibility that fatty acids change PI(4,5)P2 membrane 
content, but they do suggest that just a fatty acid tail or backbone like that from PI(4,5)P2 is not 
sufficient for channel potentiation.  
My data suggested that TMEM16A current rundown in the excised patch was caused by 
PI(4,5)P2 depletion. I therefore reasoned that scavenging PI(4,5)P2 present in the patch should 
speed TMEM16A current rundown. Indeed, application of either PI(4,5)P2-scavanging 
compounds, anti-PI(4,5)P2 or neomycin, sped TMEM16A current rundown (Figure 3-6). Other 
groups have shown that anti-PI(4,5)P2 and neomycin effectively scavenged PI(4,5)P2 without 
disrupting ion conductance during single channel recordings [116] or in excised macropatches 
expressing the inwardly rectifying K+ channels [117, 118]. These data are consistent with the 
depletion of PI(4,5)P2 causing current rundown. 
3.3.2 PI(4,5)P2 dephosphorylation promotes current rundown 
PI(4,5)P2 depletion occurs in excised patches due to the continued activity of membrane-
associated phosphatases which dephosphorylate the inositol head group without the activity of the 
counter-acting kinases. If TMEM16A current rundown in excised patches is the result of PI(4,5)P2 
dephosphorylation, I predicted that by enabling kinases to rephosphorylate the lipid or by 
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inhibiting phosphatase activity, I ought to be able to slow current rundown. Indeed, providing 
patches with Mg-ATP to fuel membrane-anchored kinases to make PI(4,5)P2, resulted in 
TMEM16A currents that ran down significantly more slowly compared to control recordings 
(Figure 3-7). While it is possible that Mg-ATP could bind to and alter the activity of other proteins 
in the excised patches, in the context of the other data included in this chapter it is likely that Mg-
ATP is fueling kinases needed to rephosphorylate PI(4,5)P2. In a parallel series of experiments, 
the broad-spectrum phosphatase inhibitor bGP [115] similarly slowed rundown by at least 3-fold. 
Together, these data demonstrate that the dephosphorylation of the inositol head group of PI(4,5)P2 
with patch excision, leads to TMEM16A current decay. These data provide additional support that 
the phosphates on the inositol head group mediate the PI(4,5)P2 potentiation of TMEM16A. 
3.3.3 Controversial TMEM16A-PI(4,5)P2 relationship 
My data directly demonstrate that PI(4,5)P2 and Ca2+ are both required for TMEM16A 
activation, yet previous studies of phospholipid regulation of this channel came to varied 
conclusions. Although agreeably demonstrating that PI(4,5)P2 modifies TMEM16A current in 
native rat isolated pulmonary cells, one study reported a decrease in whole cell Ca2+-activated Cl- 
currents with the application of diC8-PI(4,5)P2 via a pipette solution [81]. This study found that 
including the PI(4,5)P2 scavenger polylysine in the pipette solution increased TMEM16A currents 
and therefore concluded that PI(4,5)P2 inhibits TMEM16A currents [81]. Using HEK293 cells 
exogenously expressing mouse TMEM16A, another group reported that neither siRNA-mediated 
knockdown of phosphatase and tensin homolog (PTEN), nor wortmannin application, altered 
TMEM16A currents [104]. Because both treatments should reduce PI(4,5)P2 content by 
diminishing the dephosphorylation of phosphatidylinositol 3,4,5-triphosphate (PIP3) into 
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PI(4,5)P2, this report concluded that PI(4,5)P2 does not regulate TMEM16A [104]. The final two 
studies on the subject also used TMEM16A transfected HEK293 cells to conclude that mouse 
TMEM16A is potentiated by PI(4,5)P2 [68, 78]. One group reported that although TMEM16A-
mediated currents did not rundown in excised inside-out patches, application of diC8-PI(4,5)P2 
increased the current [68]. In this same study, activation of a co-expressed voltage-sensing 
phosphatase reduced, but did not abolish, TMEM16A currents [68]. A final study reported that 
fatty acids, including PI(4,5)P2, potentiate TMEM16A conducted currents [78]. My data, by 
contrast, indicate that the lipid tail alone is unable to regulate TMEM16A currents. A possible 
explanation for the difference between my data and the finding that other fatty acids potentiate 
TMEM16A is that stearic acids, including those used during these particular experiments, can 
associate with PI(4,5)P2 [119]. Consequently, stearic acids could alter membrane PI(4,5)P2 and 
therefore alter TMEM16A-conducted currents. I sought to resolve these seemingly conflicting 
results by recording from natively expressed TMEM16A channels in X. laevis oocytes to 
determine if PI(4,5)P2 regulates TMEM16A gating. Using direct experimental methods, here I 
demonstrate that TMEM16A requires both membrane PI(4,5)P2 and intracellular Ca2+ to conduct 
currents in X. laevis oocytes.  
3.3.4 Mechanism of PI(4,5)P2 regulation of TMEM16A 
Despite my demonstration that TMEM16A gating is regulated by PI(4,5)P2, the exact 
mechanism involved is yet to be determined. PI(4,5)P2 regulates other ion channels by diverse 
mechanisms [103]. For example, PI(4,5)P2 may regulate TMEM16A currents by acting on an 
accessory protein, exemplified by PI(4,5)P2 binding to KCNE1 to regulate currents conducted by 
the voltage-gated potassium channel KCNQ1 [120]. Alternatively, PI(4,5)P2 can form electrostatic 
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interactions between a cluster of positive charges on a channel and the negative charges on the 
phosphoinositol head of PI(4,5)P2 as has been observed for transient receptor potential vanilloid 5 
(TRPV5) [121], inward-rectifier K+ (Kir2.2) [122] and G protein-gated K+ (GIRK2) [123]. Unlike 
KCNQ1, no accessory protein has been revealed for TMEM16A. Although Cl- channel accessory 
1 (CLCA1) has been identified as an accessory protein for TMEM16A channels [124], neither this 
protein nor the RNA are found in mature X. laevis eggs, or the fertilization-incompetent oocytes 
[125-127]. My data, however, does not preclude an indirect mechanism for PI(4,5)P2 regulation of 
TMEM16A by another accessory protein for TMEM16A. I speculate that TMEM16A and 
PI(4,5)P2 may form electrostatic interactions similar to those revealed by the TRPV5, Kir2.2 and 
GIRK2 PI(4,5)P2-bound structures.  
Electrostatic interactions mediate PI(4,5)P2 binding to the closely-related cation channel, 
TMEM16F [73]. The putative PI(4,5)P2 binding site in TMEM16F is comprised of positively 
charged residues and neutralizing these residues perturbed PI(4,5)P2’s ability to potentiate 
TMEM16F currents [73]. It is possible that a conserved domain mediates PI(4,5)P2 interactions 
with all TMEM16 family proteins including TMEM16A channels. Although the binding domain 
may be shared, the effects on proteins will most certainly differ. For example, the Ca2+ activated 
Cl- channel TMEM16B, is inhibited by PI(4,5)P2  [68]. Yet, a shared PI(4,5)P2 regulation amongst 
TMEM16 family proteins is perhaps not surprising given that this protein family includes several 
lipid scramblases whose physiologic function requires their interaction with charged lipids.  
3.3.5 Physiological implications of TMEM16A’s regulation by PI(4,5)P2 
A requirement for PI(4,5)P2 in TMEM16A activation is intriguing because the PI(4,5)P2 
cleavage into IP3 to signal Ca2+ release from the ER would seemingly oppose the ability of 
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increased Ca2+ to activate the channel. Yet, independent studies have revealed that an IP3-evoked 
Ca2+-release from the ER opens TMEM16A channels to signal diverse physiologic processes 
including signaling contraction of lymphatic vessels [128, 129] to activation of the fast polyspermy 
block [126, 130]. I propose that in systems that use an IP3 pathway to activate TMEM16A 
channels, the amount of PI(4,5)P2 cleaved in order to generate IP3 matters greatly. For example, 
stimuli that evoke the cleavage of only a moderate amount of PI(4,5)P2 to increase IP3 and evoke 
a Ca2+ release from the ER will ultimately signal the opening of more TMEM16A channels 
compared to other stimuli that signal the cleavage of most of the membrane PI(4,5)P2 to increase 
IP3 and evoke an even larger Ca2+ release from the ER. Perhaps TMEM16A discriminates its own 
Ca2+ signal from Ca2+ signaling cascades that exclude it by seeking interactions with PI(4,5)P2 at 
the plasma membrane. Moreover, these studies reveal that the physiologic mechanisms underlying 
TMEM16A opening are more complicated than simply the presence or absence of intracellular 
Ca2+, thereby enabling TMEM16A to play diverse roles in different cell types. 
3.3.6 Summary 
 Understanding how the channel is regulated lays the conceptual framework for drugging 
this interaction in disease.  In hypertension, the over-constriction of vessels can be alleviated by 
inhibiting Ca2+-activated-Cl- channels like TMEM16A [131]. In cystic fibrosis, a condition arising 
from a dysfunctional Cl- channel, increasing TMEM16A activity could rescue the defects caused 
by poor Cl- transport [132]. By understanding the interaction between PI(4,5)P2 and TMEM16A, 
drugs targeting the PI(4,5)P2-TMEM16A interaction site can be designed to either inhibit 
TMEM16A activity with the benefit of lowering blood pressure or increase its activity to promote 
Cl- transport. 
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3.4 Figures and tables 
  
Figure 3-1. Structure of phosphatidyl 4,5-bisphosphate (PI(4,5)P2) 
 PI(4,5)P2 is a fatty acid embedded in the inner leaflet of the plasma membrane. It is made of a fatty acid tail (blue), a 
phosphate groug attaching the inositol head to the fatty acid tail and negatively charged phosphate groups at positions 
4 and 5 of the inositol head. 
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Figure 3-2. TMEM16A Ca2+-evoked Cl- currents rundown in excised inside-out patches 
Inside-out patch clamp recordings were conducted on macropatches excised from X. laevis oocytes. (A)  Example 
currents recorded during 100-150 ms steps to -60 and +60 mV, at indicated times following patch excision. (B) 
Representative plot of current  measured at -60 (bottom) or +60 mV (top) versus time, after patchexcision. 2 mM Ca2+ 
was applied at 10 s as denoted by the grey bar.The dashed grey line represents 0 nA.(C) Normalized plot of current 
measured at -60 mV versus time, fit with a single exponential (red line). (D) Box plot distribution of the  rate of current 
decay (t), measured by fitting plots of relative current versus time  with single exponentials (N  = 15). The central line 
denotes the median, the box denotes the distribution of 25-75 % of the data, and the whiskers represent 10-90% of the 
data. The t at +60 mV and -60 mV were not significantly different (P=0.29) as determined by t-test. 
t 
(s
) 
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Table 3-1. Altering PI(4,5)P2 altered the rate of rundown 
Condition Concentration Tau, t (s) Number of trials 
Control  68.9 ±7.1 N = 15 
Anti-PI(4,5)P2 15 µg/mL 48.6 ± 7.4 N = 4 
Neomycin 50 mM 32.0 ± 8.8 N = 5 
Mg-AMP 1.5 mM 57.7 ± 12.6 N = 5 
Mg-ATP 1.5 mM 143.4 ± 17.2 N = 5 
bGP 50 mM 168 ± 14.7 N = 5 
 
The mean ± SEM for the indicated measurements taken from excised inside-out patches. The t was obtained by fitting 
plots of the currents versus time with single exponential functions. 
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Figure 3-3. Rate of TMEM16A Ca2+-evoked Cl- current rundown not determined by peak currents 
Nominal TMEM16A Ca2+-evoked Cl- currents were plotted against their rates of current rundown in excised inside-
out patches from X. laevis oocytes (N=15). 
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Figure 3-4. PI(4,5)P2 analog or natural PI(4,5)P2 with Ca2+ recovered TMEM16A conducted currents 
following rundown 
The soluble synthetic analog of PI(4,5)P2 (diC8-PI(4,5)P2) or natural PI(4,5)P2 was applied to excised inside-out 
patches once current had stably rundown. Currents were recorded at -60 mV. (A) Schematic depiction of natural 
PI(4,5)P2 and diC8-PI(4,5)P2. (B) Representative plot of normalized currents versus time, before and during 
application of 100 μM diC8-PI(4,5)P2 with 2 mM Ca2+. (C) Representative plot of normalized currents versus time, 
before and during application of 100 μM natural PI(4,5)P2 with added Ca2+(N=6). (D) Box plot distribution of the fold 
current recovered after the application of natural PI(4,5)P2 with added Ca2+(N=6). Representative plots of normalized 
currents versus time, before and during application of 10 μM diC8-PI(4,5)P2 with added Ca2+ (E) and 30 μM diC8-
PI(4,5)P2 with added Ca2+ (F). Fold current recovered by natural PI(4,5)P2 with added Ca2+ compared to 100 μM diC8-
PI(4,5)P2 was not significantly different (P=0.06) as determined by t-test. (G) Plot of the average fold of current 
recovered by diC8-PI(4,5)P2 at 10, 30 and 100 μM diC8-PI(4,5)P2 addition in the presence of 2 mM Ca2+. The fold 
change in current recovered was calculated as change in current upon application of diC8-PI(4,5)P2 with Ca2+. The 
grey lines denote the box plot distribution of fold current recovered from patches recorded with 100 μM diC8-PI(4,5)P2 
with Ca2+ application, where the solid grey line represents the median value and the dashed lines represent the control 
data distribution from 25-75%.  
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Figure 3-5. PI(4,5)P2 and Ca2+ are both required for TMEM16A conducted currents 
diC8-PI(4,5)P2 and PI (diC8-PI) were applied to excised inside-out patches once current had stably rundown. Currents 
were recorded at -60 mV. (A) Schematic depiction of the diC8 analogs used. (B) Box plot distribution of the fold 
current recovered after the application of diC8-PI(4,5)P2 with Ca2+, diC8-PI(4,5)P2 without Ca2+, and diC8-PI with 
Ca2+. The fold change in current recovered was calculated as change in current upon application of diC8-PI(4,5)P2 
with Ca2+(N=7) or diC8-PI(4,5)P2 without Ca2+ (N=5), diC8-PI (N=6) addition to the peak current observed after each 
synthetic analog addition. Representative plots of normalized currents versus time, before and during application of 
100 μM diC8-PI(4,5)P2 with no added Ca2+ (C),100 μM diC8-PI with 2 mM Ca2+(D). ** denotes P< 0.01 and * denotes 
P< 0.05 as determined by t-test. Fold current recovered by diC8-PI(4,5)P2 without Ca2+ compared to diC8-PI was not 
significantly different (P=0.20). 
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Figure 3-6. Scavenging PI(4,5)P2 sped TMEM16A current rundown in excised inside-out patches 
(A) Schematic depicting membrane-embedded TMEM16A with the PI(4,5)P2 scavengers, anti-PI(4,5)P2 or neomycin. 
(B) Box plot distribution of the rate of rundown observed from currents recorded at -60 mV from inside-out patches 
exposed to 2 mM Ca2+ with 15 μg/mL anti-PI(4,5)P2 (N=4) or 50mM neomycin (N=5). The rate of current rundown  
was obtained by fitting  the plots of the current versus time witha single exponential. The grey lines denote the box 
plot distribution of the rate of rundown measured from patches recorded under control conditions of 2 mM Ca2+-only 
application, where the solid grey line represents the median value and the dashed lines represent the control data  
distribution from 25-75%. Representative plots of Ca2+-evoked Cl- currents recorded at -60 mV, versus time, from 
inside-out patches in the presence of 2 mM Ca2+with 15 μg/mL anti-PI(4,5)P2 (C) or 50mM neomycin (D); both 
conditions  sped current rundown when compared to the control denoted by the grey dashed line.* denotes P< 0.05 
determined by t-test. 
t 
(s
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Figure 3-7. Enabling rephosphorylation or inhibiting phosphatases slowed current decay in excised inside-out 
patches 
(A) Schematic depicting the role of phosphatases and kinases in generating various phosphoinositide species. (B) The 
box plot distribution of the rate of rundown (t) observed from currents recorded at -60 mV from inside-out patches 
exposed to 2 mM Ca2+ with 1.5 mM Mg-AMP (N=5), 2 mM Ca2+ with 1.5 mM Mg-ATP (N=6), and 2 mM Ca2+ with 
50 mM sodium b-glycerophosphate pentahydrate (bGP) (N=6). Single exponentials were fitted to current traces to 
obtain the rate of current rundown. Solid grey line denotes median rate of rundown measured from patches recorded  
under the control conditions of 2 mM Ca2+-only application, and the dashed lines represent the control data distribution 
from 25-75%. Representative plots of normalized currents versus time made before and during application of 1.5 mM  
Mg-AMP with 2 mM Ca2+ (compared to 2 mM Ca2+-only application with the grey dashed line) (C), 1.5 mM Mg-ATP 
with 2 mM Ca2+ (compared to 1.5 mM Mg-AMP with  the orange dashed line) (D), and 50 mM bGP with 2 mM Ca2+ 
(compared to 2 mM Ca2+-only application with the grey dashed line) (E). ** denotes P< 0.01 and * denotes P < 0.05 
when compared to 2 mM Ca2+-only application or between indicated pairs determined by t-test. 
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4.0 The Rate of TMEM16A Current Rundown Depends on Intracellular Ca2+ 
This chapter is an adaptation of 2020 Tembo et al. to be submitted to the Journal of 
Biological Chemistry. 
4.1 Introduction 
Cl- channels contribute substantially to the regulation of excitable cells [128, 129, 133]. 
The ability of cellular membranes to shift between positive and negative potentials enables our 
neurons to relay information and our heart to beat. Thus, homeostatic ionic environments are key 
for proper functioning of excitable cells whose greater physiological roles are achieved through 
changes in membrane potential. A crucial protein regulating membrane potential is the Ca2+-
activated Cl- channel TransMEMbrane 16A (TMEM16A). The disruption of TMEM16A leads to 
perinatal lethality in mice, revealing a critical role for TMEM16A in the quality of life [100]. 
TMEM16A is a key component regulating important physiological roles including smooth muscle 
contraction [79, 95, 97] and dorsal root ganglion signal transduction [79, 134]. TMEM16A 
channels are also as key players in diseases such as hypertension and cancer [128, 129, 133, 135]. 
Now that we have established a role for TMEM16A across different cell types and disease, 
an area needing further study is how these channels are regulated. Understanding TMEM16A 
regulation will lay the conceptual framework for the development of TMEM16A-based therapy. 
TMEM16A requires its ligand, Ca2+, and its cofactor, phosphatidylinositol 4,5-bisphosphate 
(PI(4,5)P2), which when present together promote the open conformation of TMEM16A [68, 78, 
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90, 136, 137]. In the absence of either Ca2+ or PI(4,5)P2 , the Cl- pore of TMEM16A is impermeable 
to Cl- [45, 46, 71]. The structure of TMEM16A has revealed that the homodimer has two Ca2+ 
binding pockets per subunit whose ability to bind Ca2+ is voltage dependent at low concentrations 
of Ca2+. Each Cl- pore was initially thought to be gated by just the binding of Ca2+ suggesting that 
Ca2+ occupancy alone would result in TMEM16A channels opening [47, 48]. However, with 
evidence that: (1) PI(4,5)P2 is a required to open TMEM16A channels, (2) fewer than two bound 
Ca2+ per dimer can activate TMEM16A in a voltage dependent manner, and (3) each pore operates 
independently, the regulation of TMEM16A gating has become complex.  
Ca2+ and PI(4,5)P2 are both required for TMEM16A to conduct Cl- currents. Ca2+ signaling 
cascades can increase intracellular Ca2+ levels to 300-400 nM in smooth muscle cells [138] or 3-
400 µM in Xenopus laevis oocytes [139]. Given that reported half maximal effective concentration 
for mouse TMEM16A (mTMEM16A) exogenously expressed in human embryonic (HEK)293 
cells is  800 nM-1.0 μM [46, 50], it is possible that TMEM16A has a mechanism in place that 
allows the channel to distinguish between various signaling cascades. As previously shown, part 
of TMEM16A’s regulation involves PI(4,5)P2 [90]. PI(4,5)P2 makes up 1-3% of the plasma 
membrane and is tightly regulated by a series of phosphoinositol kinases and phosphatases [140, 
141]. Local PI(4,5)P2 concentrations can even be higher where it is needed [142]. For example at 
intracellular vesicle docking sites on the plasma membrane of neurons, PI(4,5)P2 is estimated to 
be 3-6% of the cell surface area [143]. It is possible that TMEM16A is in close proximity to 
PI(4,5)P2 most of the time especially in cells where it is endogenously expressed. Constant 
PI(4,5)P2 abundance and regular Ca2+ signaling cascades could mean that a tight regulation is 
needed either directly acting on TMEM16A itself or Ca2+ or PI(4,5)P2. 
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The objective of the research reported in this chapter was to determine how TMEM16A 
activity is tightly regulated by Ca2+ and PI(4,5)P2. Specifically, I examined how PI(4,5)P2 and Ca2+ 
alter the opening and closing of TMEM16A channels. For these experiments, I conducted inside-
out patch clamp recordings on the endogenous TMEM16A channel in Xenopus laevis oocytes. In 
examining how PI(4,5)P2 gates TMEM16A, I found that the phosphate at position 4 of PI(4,5)P2 
is key in mediating the TMEM16A-PI(4,5)P2 interaction. In examining how Ca2+ gates 
TMEM16A, I found that altering Ca2+ concentration altered the speed of current rundown. 
Specifically, I found that lower concentrations of Ca2+ or Ca2+ substitutions resulted in slowed 
TMEM16A current rundown. Next, I determined that inhibiting PLCs significantly slowed current 
rundown during the application of a general PLC inhibitor but not its analog. Taken together, my 
data provide insight on how PI(4,5)P2 and Ca2+ regulate TMEM16A channels in X. laevis oocytes. 
4.2 Results   
4.2.1 PI(4,5)P2 does not recover TMEM16A currents completely 
TMEM16A is activated by 2 mM Ca2+ and within seconds of application, the current peaks 
and then slowly runs down in excised inside-out patches of X. laevis (Figure 4-1A). Consistent 
with Figure 3-2, TMEM16A currents recorded in 2 mM Ca2+ during 100-150 ms steps to -60 mV 
and +60 mV are recovered by dioctanoyl-phosphatidyl 4,5-bisphopshate (diC8-PI(4,5)P2) (Figure 
4-1B). Interestingly, diC8-PI(4,5)P2 did not recover currents completely (Figure 3-2)  even though 
Figure 3-3 suggested that the phosphates on the inositol head of diC8-PI(4,5)P2 were necessary 
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and sufficient to recover TMEM16A Ca2+-evoked Cl- currents. Thus I sought to understand the 
relationship between TMEM16A current recovery and the phosphates on diC8-PI(4,5)P2. 
4.2.2 Phosphate at position 4 of the inositol ring is key in PI(4,5)P2’s interaction with 
TMEM16A 
I tested the hypothesis that application of an analog of PI(4,5)P2 with more phosphates and 
therefore an increased negative charge on the inositol head would recover TMEM16A currents 
following rundown. To do so, I applied a water-soluble analog of phosphatidyl 3,4,5-trisphopshate 
(diC8-PIP3) to excised inside-out patches after current had stably rundown. I recorded TMEM16A-
conducted currents at -60 mV before and during application of 100 µM diC8-PIP3 (at the same 
concentration that I observed the greatest TMEM16A current recovery for diC8-PI(4,5)P2). In five 
independent trials, I observed that 100 µM diC8-PIP3 application recovered an average of 2.8 ± 
0.4-fold current (Figure 4-1C) which was not more than the 3.6 ± 0.5-fold recovery by diC8-
PI(4,5)P2. Figure 4-1D depicts an example plot of TMEM16A-conducted currents recorded at -60 
mV versus time before and during diC8-PIP3 application. Because the current recovered by diC8-
PIP3 was not greater or equal to the current recovered by diC8-PI(4,5)P2, these data suggest that 
negative charge carried by the phosphate groups alone is insufficient in regulating TMEM16A 
currents.  
Given that diC8-PIP3 resulted in less current recovery than diC8-PI(4,5)P2, I reasoned that 
either the third phosphate in the inositol ring introduced steric hinderance inositol ring in 
TMEM16A-PI(4,5)P2 interaction or that PIP3 must first be dephosphorylated to interact 
TMEM16A. Thus, I next examined whether charge alone was sufficient to recover TMEM16A 
currents or if phosphate position mattered for TMEM16A current recovery. I began by testing the 
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idea that having two phosphates (two negatively charged groups and not greater) on the inositol 
head was sufficient for recovering TMEM16A currents. To explore this possibility, I sought to 
determine if application of other phosphoinositides containing two negatively charged phosphates 
on the inositol ring would recover Ca2+-evoked TMEM16A Cl- currents. I applied a water-soluble 
analog of phosphatidyl 3,4-bisphopshate (diC8-PI(3,4)P2) to excised inside-out patches after 
current had stably rundown. I recorded TMEM16A-conducted currents at -60 mV before and while 
applying 100 µM diC8-PI(3,4)P2. In five independent trials, I observed that 100 µM diC8-
PI(3,4)P2 application recovered an average of 2.8 ± 0.9-fold current (Figure 4-1C). The currents 
recovered were similar to those observed by the application of diC8-PI(4,5)P2. Figure 4-1E depicts 
an example plot of TMEM16A-conducted currents recorded at -60 mV versus time before and 
during diC8-PI(3,4)P2 application.  
Surprisingly, TMEM16A-conducted currents recorded at -60 mV before and during 
application of 100 µM diC8-PI(3,5)P2 recovered 1.1 ± 0.1-fold current in five independent trials 
(Figure 4-1C). This level of current recovered was substantially smaller than the currents recovered 
by the equally charged species diC8-PI(4,5)P2 and diC8-PI(3,4)P2. Figure 4-1F depicts an example 
plot of TMEM16A-conducted currents recorded at -60 mV versus time before and during diC8-
PI(3,5)P2 application. The current recovered by diC8-PI(3,5)P2 was less than the current recovered 
by both diC8-PI(4,5)P2 and diC8-PI(3,4)P2. These data also suggest that the negative charge alone 
does not account for the TMEM16A-PI(4,5)P2 interaction. Both diC8-PI(3,5)P2 and diC8-
PI(3,4)P2 carry the same number of phosphates and charge as diC8-PI(4,5)P2, yet diC8-PI(3,5)P2 
and diC8-PI(3,4)P2 are unable to recover currents equal to diC8-PI(4,5)P2. However, diC8-
PI(3,4)P2 did recover currents similar to diC8-PI(4,5)P2. Perhaps in addition to having two 
negatively charged phosphates on the inositol head, TMEM16A prefers the two phosphates occupy 
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specific positions on the inositol head. Specifically, the phosphoinositides diC8-PI(3,4)P2 and 
diC8-PI(4,5)P2 that recovered TMEM16A conducted currents had a phosphate at position 4, but 
diC8-PI(3,5)P2 which lacks a phosphate at position 4 of the inositol head was unable to recover 
substantial TMEM16A conducted currents. 
To more directly explore a possible relationship between phosphate position and 
TMEM16A current recovery, I recorded TMEM16A-conducted currents at -60 mV before and 
while applying water soluble analogs of the phosphoinositol monophosphates. I tested the 
hypothesis that phosphate position was mediating TMEM16A current recovery. I first assessed if 
the phosphate at position 4 was indeed important for TMEM16A to conduct Cl- currents. I applied 
the water-soluble analog of phosphatidyl 4-monophosphate (diC8-PI(4)P) to excised inside-out 
patches after current had stably rundown. I recorded TMEM16A-conducted currents at -60 mV 
before and during application of 100 µM diC8-PI(4)P. In nine separate trials, I observed that 100 
µM diC8-PI(4)P application recovered 2.1 ± 0.2-fold current (Figure 4-1C). The currents 
recovered by diC8-PI(4)P were similar albeit smaller than the fold recovery observed when diC8-
PI(4,5)P2 was applied (Figure 4-1C) which was consistent with the idea that the 4 position was 
important for TMEM16A current recovery. Figure 4-1G depicts an example plot of TMEM16A-
conducted currents recorded at -60 mV versus time before and during diC8-PI(4)P application. 
Albeit recovering less current than diC8-PI(4,5)P2, diC8-PI(4)P showed an intermediate recovery 
(lying between 3.6 ± 0.5-fold current recovered by diC8-PI(4,5)P2 with Ca2+ and 1.4 ± 0.2-fold 
current recovered by diC8-PI with Ca2+ (Figure 4-1C)). 
Next, I assessed if having phosphates at positions 3 and 5 of the inositol head would also 
result in TMEM16A current recovery. I applied the water-soluble analog of phosphatidyl 3-
monophosphate (diC8-PI(3)P) to excised inside-out patches after current had stably rundown. I 
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recorded TMEM16A-conducted currents at -60 mV before and during application of 100 µM 
diC8-PI(3)P and observed 1.5 ± 0.3-fold current recovery in five separate trials. Figure 4-1H 
depicts an example plot of TMEM16A-conducted currents recorded at -60 mV versus time before 
and during diC8-PI(3)P application. diC8-PI(3)P recovered less current than both diC8-PI(4,5)P2 
and diC8-PI(4)P. This was also true for diC8-PI(5)P. I also recorded TMEM16A-conducted 
currents at -60 mV before and during application of 100 µM diC8-PI(5)P. In five separate trials I 
observed that diC8-PI(5)P only recovered 1.3 ± 0.1-fold current (Figure 4-1C). Figure 4-1I depicts 
an example plot of TMEM16A-conducted currents recorded at -60 mV versus time before and 
during diC8-PI(5)P application. I observed a lower fold recovery for diC8-PI(5)P than diC8-PI(4)P 
even though PI(4,5)P2 is composed of phosphates at position 4 and 5. Notably, application of diC8-
PI(3,5)P2 (Figure 4-1C) did not recover substantial currents which was consistent with our 
observation here that neither diC8-PI(3)P nor diC8-PI(5)P recovered TMEM16A currents. 
Overall, the phosphoinositide data collected demonstrated that diC8-PI(4)P, diC8-PI(3,4)P2 and 
diC8-PIP3 recovered intermediate or similar current to diC8-PI(4,5)P2. Each of these 
phosphoinositides has a phosphate at position 4 of the inositol head. 
Across all the phosphoinositides tested, I observed that having a phosphate at position 4 of 
the inositol head elevated the TMEM16A current recovered. These data suggest that TMEM16A 
interacts with PI(4,5)P2 in a way relying on the phosphate at position 4 is to keep TMEM16A 
channels open. 
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4.2.3 The Xenopus voltage sensing phosphatase does not completely inhibit TMEM16A 
currents 
My findings thus far suggested that the phosphate at position 4 was critical for the recovery 
of TMEM16A currents recorded following rundown. Next, I explored the importance of the 
phosphate at this position further. I reasoned that if the phosphate at position 4 was the most 
important for PI(4,5)P2 regulation of TMEM16A then removal of the phosphate at position 5 
should not substantially alter current. To test this hypothesis, I expressed the Xenopus laevis 
voltage sensing phosphatase (Xl-VSP) in excised patches (Figure 4-2A). After confirming VSP 
expression (Figure 4-2B) I proceeded to record TMEM16A Ca2+-evoked Cl- currents. In five 
independent trials, I recorded TMEM16A-conducted currents at -60 mV before and during the 
application of 2 mM Ca2+ in patches while activating Xl-VSP at depolarizing potentials (+60 mV). 
I observed that the rate of current rundown in patches expressing Xl-VSP at the membrane was an 
average rate of 61.2 ± 3.0 s (Table 4-1) and was not significantly different compared to control 
current rundown which ran down at an average rate of 86.0 ± 1.6 s (Figure 4-2C). Figure 4-2D 
depicts an example plot of TMEM16A-conducted currents recorded at -60 mV versus time after 
activating Xl-VSP. Unlike others who reported a significant depletion in TMEM16A conducted 
currents after activating a VSP [68, 78], I observed a slight depletion of TMEM16A conducted 
currents. The lack of significant difference in the rate of TMEM16A current depletion by the VSP 
is consistent with the hypothesis that the phosphate at position 4 is important for TMEM16A 
regulation. 
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4.2.4 Lowering applied intracellular Ca2+ concentration slows current rundown 
Despite finding that phosphate position is important in mediating TMEM16A-PI(4,5)P2, 
none of the phosphoinositides containing a phosphate at position 4 of the inositol head were able 
to completely recover TMEM16A currents. Aside from membrane phosphatases 
dephosphorylating PI(4,5)P2 and thereby depleting it, I hypothesize that Ca2+ may be acting on the 
patch by a TMEM16A-independent mechanism to speed PI(4,5)P2 decay in excised patches. 
I then asked if current rundown was independent of the Ca2+ concentration. I sought to 
assess the rate of rundown using various concentrations of Ca2+ to test my hypothesis that Ca2+-
evoked TMEM16A Cl- currents would rundown in lower concentrations of Ca2+. I recorded 
TMEM16A currents during 100-150-ms steps to -60 mV and +60 mV. I observed that lowering 
the concentrations of Ca2+ affected my ability to activate the channel. For instance, 2 mM Ca2+ 
resulted in peak TMEM16A currents almost immediately after Ca2+ application (Figure 4-3A) but 
20 µM Ca2+ did not activate TMEM16A channels (Figure 4-3B). By contrast 50 µM Ca2+ activated 
TMEM16A channels whose currents delayed to peak (Figure 4-3C). However, when I applied 100 
µM Ca2+ (Figure 3D) or 500 µM Ca2+ (Figure 4-3E), I observed currents that peaked within 
seconds of Ca2+ application (Figure 3F). 100 µM is a reported saturating concentration for 
mTMEM16A [136]. Interestingly, I found that even though 100 µM Ca2+ could activate 
xTMEM16A, these currents ran down at a rate of 755 ± 388 s which is much slower than the 
control which ran down at a rate of 86 ± 7.6 s (Figure 4-4A). Figure 4-4B depicts an example plot 
of normalized TMEM16A-conducted currents recorded at -60 mV versus time before and during 
100 µM Ca2+ application. 
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As done with 100 µM, I recorded TMEM16A currents during 100-150-ms steps to -60 mV 
and +60 mV. I found that at this concentration of Ca2+, TMEM16A currents ran down at a rate of 
216.3 ± 45 s, which was faster than the currents recorded at 100 µM Ca2+, but still ran down slower 
than the controls recorded during 2 mM Ca2+ application (Figure 4-4A). Figure 4-4C depicts an 
example plot of TMEM16A-conducted currents recorded at -60 mV versus time before and during 
500 µM Ca2+ application. Despite TMEM16A currents running down at 100 and 500 µM Ca2+, the 
rate of TMEM16A current rundown was slower than observed at 2 mM Ca2+ (Figure 4-4B). These 
data suggest that high Ca2+ concentrations speed TMEM16A current rundown. 
To further evaluate the effect of the 2 mM Ca2+ on the rate of current rundown, I recorded 
TMEM16A conducted currents during 100-150-ms steps to -60 mV and +60 mV while alternating 
the application 2 mM Ca2+ and 0 mM Ca2+. I reasoned that if 2 mM Ca2+ was speeding rundown 
then short applications of 2 mM Ca2+ could enable me to speed rundown during application 
intervals. I recorded TMEM16A currents during 100-150-ms steps to -60 mV and +60 mV before 
and during the alternating application of 2 mM Ca2+ and 0 mM Ca2+ during 10 s intervals. In four 
independent trials, I observed substantial current rundown. Figure 4-4D depicts an example plot 
of TMEM16A-conducted currents recorded at -60 mV versus time before and during alternating 
between 2 mM Ca2+ and 0 mM Ca2+ application. I evaluated the rate of current rundown by also 
fitting the traces with a single exponential. I observed that even short exposures to 2 mM Ca2+ sped 
current rundown so that it was 47.1 ± 4.9 s which is slightly faster than observed for the 2 mM 
Ca2+ controls (Figure 4-4B). These data suggest that indeed the high concentration of Ca2+ is 
speeding current rundown. 
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4.2.5 Complete Ca2+ substitution slows TMEM16A current rundown 
The finding that PI(4,5)P2 depletion resulted in TMEM16A current rundown, and that 2 
mM Ca2+ sped rundown suggested that there could be a relationship between PI(4,5)P2 depletion 
and Ca2+ concentration. Lower concentrations of Ca2+ also have slower rates of rundown (Figure 
4-4). Therefore, it is possible that Ca2+ itself is acting to speed PI(4,5)P2 depletion in inside-out 
excised patches. Ca2+ is a cell signaling molecule that can have vast effects on cell signaling that 
could be contributing to its ability to speed rundown. Thus, I reasoned that if Ca2+ was acting in a 
TMEM16A independent mechanism then a complete substitution of Ca2+ with other divalent 
cations that activate the channel should slow TMEM16A current rundown to illustrate a specific 
role for Ca2+[50, 144, 145]. I tested this hypothesis by quantifying the rate of TMEM16A rundown 
during the application of the divalent cation Ni2+. I began these experiments by recording 
TMEM16A-conducted currents before and during the application of 2 mM Ni2+. In five 
independent trials, I observed that TMEM16A current ran down slower than the Ca2+ controls at 
an average rate of 468.6 ± 176 s (Figure 4-5A). Figure 4-5B depicts an example plot of current 
versus time at -60 mV before and during the application of 2 mM Ni2+. Substituting 2 mM Ca2+ 
with 2 mM Ni2+ slowed TMEM16A current rundown suggesting that Ca2+ not Ni2+ is capable of 
increasing PI(4,5)P2 depletion. 
Altogether, I have observed that Ni2+ activated TMEM16A and slowed current rundown. 
At this concentration of Ni2+, TMEM16A currents are observed within a few seconds of 
application of Ni2+and begin to rundown shortly after peaking. However, unlike 2 mM Ca2+, Ni2+ 
slowed current rundown despite being applied at the same ionic concentration as Ca2+. These data 
suggest that Ca2+ has unique effects on the patch that are not replicated by Ni2+. Nevertheless, these 
data point to Ca2+ regulating TMEM16A currents in a Ca2+ concentration dependent way. 
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Together, these findings reveal that Ca2+ speeds current rundown in a channel-independent mode. 
This is consistent with my hypothesis that high Ca2+ concentrations speed TMEM16A current 
rundown, but how this relates TMEM16A channels closing is yet to be determined. 
4.2.6 Inhibition of phospholipase C (PLC) slows rundown 
One possible mechanism by which Ca2+ can speed PI(4,5)P2 depletion in excised patches 
is by activation of membrane anchored phospholipase C. Given that I previously reported that the 
addition of 2 mM Ca2+ supplemented with 1.5 mM Mg-ATP or 50 mM bGP slowed TMEM16A 
current rundown (Figure 3-5), it is likely that PI-4 and PI-5 phosphatases contribute to PI(4,5)P2 
depletion in excised patches. However, the inability for 1.5 mM Mg-ATP or bGP to completely 
prevent TMEM16A current rundown suggested that another membrane component may also 
contribute to PI(4,5)P2 depletion.  
 Ca2+ is a master signaling molecule playing an essential role in mediating responses to 
cellular signals, GPCRs and other cell receptors [146]. Ca2+ also activates ion channels either by 
directly binding to them or binding adaptor proteins which in turn activate ion channels [147]. Ca2+ 
also promotes phospholipase C (PLC) activity which results in the hydrolysis of PI(4,5)P2 into 
DAG and IP3 [148, 149]. 
I reasoned that 2 mM Ca2+ could activate some PLC isoforms to cause PI(4,5)P2 depletion 
to speed rundown of TMEM16A currents in excised patches (Figure 4-6A). To test this hypothesis, 
I recorded TMEM16A Ca2+-evoked Cl- currents during the application of 2 mM Ca2+ 
supplemented with the general PLC inhibitor U-73122 [150, 151]. I recorded TMEM16A Ca2+-
evoked Cl- currents during the application of 2 mM Ca2+ supplemented with 1 µM U-73122. I 
observed that in the presence of both 2 mM Ca2+ and U-73122, current rundown was slowed. In 
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five independent trials, the average rate of current rundown was 253 ± 83 s (Figure 4-6B). Figure 
6C depicts an example plot of current versus time at -60 mV before and during the application of 
2 mM Ca2+ supplemented with 1 µM U73122. These data suggest that a PLC contributes to the 
rate of TMEM16A current rundown by speeding it. Thus, not only can Ca2+ bind TMEM16A to 
activate it, Ca2+ can activate Ca2+ sensitive PLCs to attenuate TMEM16A activity at high 
concentrations in inside-out excised patches. Therefore, TMEM16A channels are regulated by 
PI(4,5)P2, whose rate of depletion is dependent on the activity of a Ca2+-sensitive PLC. 
Next, I evaluated the effects of U-73343, the inactive analog of U-73122, on current 
rundown. I recorded TMEM16A Ca2+-evoked Cl- currents during the application of 2 mM Ca2+ 
supplemented with U-73343 [150, 151]. I observed that in the presence of both 2 mM Ca2+ and 1 
µM U-73343, TMEM16A currents ran down quite quickly. In four independent trials, the current 
rundown at a rate of 128 ± 38 s which was not different from the controls that ran down at a rate 
of 86 ± 7.6 s (Figure 4-6B). Figure 4-6D depicts an example plot of normalized current versus time 
at -60 mV before and during the application of 2 mM Ca2+ supplemented with 1 µM U73343. 
Admittedly, U-73343 also slowed current rundown although this effect was not significant. 
Because the rate of current rundown was not significantly different from the control, I decided to 
use U-73343 as a control for U-73122. These data suggest that a PLC contributes to the rate of 
TMEM16A current rundown by speeding it. Thus, not only can Ca2+ bind TMEM16A to activate 
it, Ca2+ can activate Ca2+ sensitive PLCs to attenuate TMEM16A activity at high concentrations 
in inside-out excised patches. Therefore, TMEM16A channels are regulated by PI(4,5)P2, whose 
rate of depletion is dependent on the activity of a Ca2+-sensitive PLC. 
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4.3 Discussion 
By recording TMEM16A currents in the presence of different phosphoinositides or altering 
Ca2+ concentrations, here I demonstrate that TMEM16A is tightly regulated via its need for the 
phosphate at the 4 position in PI(4,5)P2 and the activation of a Ca2+-sensitive PLC in these inside-
out excised patches. The requirement for both PI(4,5)P2 and Ca2+ was established [68, 78, 128] but 
the mechanism behind this Ca2+-TMEM16A-PI(4,5)P2 relationship was not clearly established. 
Here, I sought to determine Ca2+ and PI(4,5)P2’s contributions to this relationship. TMEM16A’s 
Ca2+ binding sites and their properties have already been determined [44, 47, 48, 50, 152-154]. 
Similarly, PI(4,5)P2 binding sites have proposed [136, 137]. Here, I uncover the characteristics of 
PI(4,5)P2 that mediate TMEM16A regulation and establish how Ca2+ acts to regulate the channel 
and PI(4,5)P2 in a channel independent mechanism. 
4.3.1 Phosphate position is key in mediating TMEM16A-PI(4,5)P2 interaction 
Application of soluble phosphoinositide analogs containing phosphates recovered 
TMEM16A conducted currents following rundown when applied in the presence of Ca2+, and the 
extent of recovery was dependent on whether a phosphate was present at position 4 of the inositol 
head (Figure 4-1). Not all TMEM16A current was recovered, but greater TMEM16A current 
recovery was observed in the presence of phosphoinositides with a phosphate at position 4 of the 
phosphoinositide head than phosphoinositides lacking a phosphate at position 4 of the inositol 
head. The phosphoinositides that recovered TMEM16A currents, namely, diC8-PI(4,5)P2, diC8-
PI(3,4)P2 and diC8-PI(3,4,5)P3 could be recovering currents due to their shorter vicinal distances 
between phosphates compared to PI(3,5)P2 where the phosphates are much farther apart. However, 
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diC8-PI(4)P recovered TMEM16A currents while lacking the benefits of phosphates being closer 
together. Instead, it is possible that the phosphate at position 4 may fit the two-step model proposed 
by others [137]. In this model, there are three PI(4,5)P2 binding sites located on TMEM16A 
containing basic residues that when neutralized reduce PI(4,5)P2 sensitivity [137]. Perhaps the 
phosphate at position 4 interacts more readily with one of these PI(4,5)P2 binding sites due to 
spatial proximity, and this specific site could be responsible for opening TMEM16A channels by 
forcing the Cl- pore open while the other two phosphate sites just enhance the opening of a pore 
already made big enough to pass Cl- by the phosphate at position 4 on the inositol head. 
Surprisingly, diC8-PI(4)P recovered substantial TMEM16A currents whereas diC8-PI(5)P 
did not. The currents recovered by these monophosphates wer not additive for currents recovered 
by PI(4,5)P2. It is possible that without a phosphate at the 4 position of the inositol head, PI(5)P 
does not access phosphoinositide binding sites. Alternatively, PI(5)P’s contribution to 
TMEM16A’s interaction with PI(4,5)P2 may be based on its negative charge and not its actual 
position. Having the additional negative charge on PI(4,5)P2 may help the stay pore in an open 
conformation [45, 46]. PI(3)P recovered little currents. 
TMEM16A prefers PI(4,5)P2 and PI(4)P over PI [90]. This supports the hypothesis that 
PI(4,5)P2 possibly carries out its interaction with TMEM16A by first interacting with the 
phosphate at position 4. Xl-VSP (Figure 4-2) trended toward speeding rundown and not 
completely eliminating TMEM16A currents. This is consistent with the idea that the phosphate at 
the 4 position on PI(4,5)P2 makes the provision for PI(4,5)P2 to interact with TMEM16A. 
Similarly, activation of another voltage sensing phosphatase, Dr-VSP, in mouse TMEM16A 
(mTMEM16A) expressing HEK293 cells reportedly resulted in the reduction of mTMEM16A 
Ca2+-evoked Cl- currents [68, 78]. As I observed in my Xl-VSP experiments, Dr-VSP was unable 
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to obliterate mTMEM16A Ca2+-evoked Cl- currents [68, 78]. It is possible that the ratio of VSP 
expressed versus the concentration of PI(4,5)P2 in any one of these cells used is not sufficient to 
completely get rid of TMEM16A currents. However, the finding that PI(4)P alone can recover 
TMEM16A currents favors the idea that even if the VSPs did dephosphorylate all the PI(4,5)P2, 
they would leave just as much PI(4)P which on its own, can potentiate TMEM16A currents. 
 
4.3.2 Ca2+ concentration determines the rate of TMEM16A current rundown 
With PI(4,5)P2 as making up 1-3% of the plasma membrane [141] and Ca2+ reaching 
concentrations as high as 400 µM in X. laevis oocyte [138], TMEM16A channels must employ 
additional regulatory mechanisms to prevent unnecessary activation from distorting the many 
physiological roles it plays. I speculate that TMEM16A channels use a combination of regulatory 
mechanisms to help determine whether to open and pass Cl-. In addition to requiring a phosphate 
at position 4 of the inositol head in phosphoinositides, TMEM16A channels need Ca2+ to become 
activated (Figure 4-1). However, how TMEM16A distinguishes between Ca2+ signals for other 
cellular functions versus its own has not been determined. Here, I show that different 
concentrations of Ca2+ produce different TMEM16A current profiles. High Ca2+ concentrations 
open TMEM16A channels quickly and result in the channels closing immediately after (Figure 4-
3 and 4-4). Low Ca2+ concentrations open TMEM16A channels slowly and result in the channels 
closing slowly over time (Figure 4-4). From these data, I speculate that TMEM16A channels are 
regulated by Ca2+ concentration. In particular, the X. laevis oocyte which eventually matures into 
an egg [155], must have a tight regulation of TMEM16A channels since they are important 
channels in preventing embryonic lethality during the early stages of egg fertilization [156].  
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To better examine Ca2+’s role in determining the rate of TMEM16A current rundown, I 
evaluated the effects of other divalents on TMEM16A current rundown. I found that Ni2+ slowed 
TMEM16A current rundown (Figure 4-5). Since Ni2+ activates TMEM16A and Ni2+ is a Ca2+-
independent mechanism of activating the channel, the data demonstrate that indeed TMEM16A 
current rundown is sped by high Ca2+ concentrations. These data also point to Ca2+ playing another 
role in the cell aside from activating TMEM16A. Ca2+ could be depleting PI(4,5)P2 in excised 
inside-out patches. PI(4,5)P2 can be depleted by its hydrolysis into IP3  and DAG by PLC in a Ca2+-
dependent manner [148, 149]. It is possible that Ca2+ promotes PI(4,5)P2 hydrolysis in the excised 
inside-out patches and in doing so, reduces the available PI(4,5)P2 able to form electrostatic 
interactions with the TMEM16A PI(4,5)P2 binding sites [136, 137]. This is consistent with the 
data showing that inhibiting PLCs with U-73122 slows current rundown (Figure 4-5). 
Although the data presented suggest that Ca2+ can both activate TMEM16A and inhibit its 
activation by depleting PI(4,5)P2, the exact mechanisms behind this two-tier regulation of 
TMEM16A has yet to be determined. A possible explanation for Ca2+’s ability to speed current 
rundown at high concentrations of Ca2+ is that at high concentrations of Ca2+ there is enough Ca2+ 
to both activate TMEM16A and also PLCs [149]. Alternatively, Ca2+ at high concentrations could 
act like Mg2+, which has been reported to scavenge PI(4,5)P2 by coordinating it via electrostatic 
interactions [157-160]. This phenomenon of charge shielding of PI(4,5)P2 has been reported for 
Mg2+ and Ca2+ [149]. Increasing the concentration of these divalents or polyamines carrying high 
positive charges results in reduced PLC activity for PLC subtypes b, d and g [149, 161]. However, 
at millimolar concentrations of these divalents, PLC activity is still as high as ~60% [149] for 
PLCb and PLCg, which are the only subtypes of PLC expressed in X. laevis [125, 162, 163]. 
Therefore, it seems unlikely that Ca2+ is preventing PI(4,5)P2 hydrolysis at 2 mM Ca2+ in the 
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context of the fast rate of current rundown observed in my experiments. Moreover, U-73122 
should not have slowed current rundown if PLCs did not play a role in speeding current rundown. 
The inactive analog of the PLC inhibitor, U-73343, slightly slowed current rundown but not 
significantly (Figure 4-5). These data suggest that a PLC is playing a role in speeding current 
rundown. 
4.3.3 Mechanism of TMEM16A regulation and the Ca2+-TMEM16A-PI(4,5)P2 relationship 
TMEM16A seemingly combines inputs from PI(4,5)P2, Ca2+ and membrane potential to 
determine channel conformation state. This multimodal regulation of TMEM16A seems to be a 
feature shared with other TMEM16 family members. TMEM16A shares voltage regulation with 
the CaCC TMEM16B [63, 64]. However, TMEM16B is instead inhibited by PI(4,5)P2 rather than 
potentiated [7]. PI(4,5)P2 regulates TMEM16F gating such that applying PI(4,5)P2 results in 
increased TMEM16F currents [73] of the reported cation channel [164]. These differences in 
TMEM16 channel regulation suggest a complex regulation of TMEM16A channel activity.  
Just like TMEM16F, TMEM16A interacts with PI(4,5)P2 through electrostatic interactions 
[73]. TMEM16A contains positively charged amino acids that when mutated reduce TMEM16A’s 
sensitivity to PI(4,5)P2 or prevent TMEM16A’s activation altogether [73, 136]. Even though 
PI(4,5)P2 uses negative charges to allow this PI(4,5)P2-TMEM16A, my data have determined that 
just the negative charges on the phosphate groups alone are not sufficient to enable this interaction. 
Therefore, it is possible that specific residues on TMEM16A interacting with the phosphate at the 
position 4 of the inositol head control this interaction. Consistent with this idea, diC8-PIP3, 
PI(3,4)P2 and PI(3,5)P2 trended toward less current recovery than diC8-PI(4,5)P2 (Figure 4-1).  
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4.3.4 Other mechanisms regulating TMEM16A gating 
At low Ca2+, Ca2+’s ability to bind the channel is voltage dependent. Regardless, 
TMEM16A currents are greater at positive membrane potentials showing TMEM16A’s voltage 
regulation [165]. When high Ca2+ is applied, both positive and negative membrane potentials result 
in robust TMEM16A currents and the voltage dependence is reduced [165]. Other than Ca2+, 
TMEM16A channel activity is modified by alternative splicing [74] volume [74, 75], acid [76], 
cholesterol [77, 78], heat [79], and phosphoinositides [80-82]. These proposed mechanisms do not 
preclude the need for Ca2+ or PI(4,5)P2. However, another proposed regulator, the Ca2+-activated 
Cl- channel regulator 1 (CLCA1) does not need Ca2+ or PI(4,5)P2 [124, 166]. CLCA1 reportedly 
regulates TMEM16A by preventing its internalization and degradation at the lysosome [124, 166]. 
Even in the presence of all these other modulators of TMEM16A, at a minimum, 
TMEM16A requires both PI(4,5)P2 and Ca2+ to conduct Cl- currents [90]. These other inputs can 
modify the activity of TMEM16A by reducing it or increasing it, but they cannot by themselves 
result in TMEM16A conducted Cl- currents. Ca2+ and PI(4,5)P2 interact with residues on 
TMEM16A and together force the necessary shifts in the TMEM16A channel parts that open the 
Cl- pore that would otherwise remain too small for Cl- passage [45, 46]. 
4.3.5 Summary 
TMEM16A activity underlies basic cellular activity including neuronal firing and heart 
contractions. As such TMEM16A dysfunction could be a threat against life. TMEM16A is capable 
of promoting life by preventing perinatal lethality during early development [100]. TMEM16A 
works to our benefit. However, when dysfunctional or overworking, as is the case in hypertension, 
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[131] or overexpressed, as is the case in cancer [167], TMEM16A becomes an adversary working 
to reduce our quality of life. By understanding how TMEM16A is regulated, we can target these 
regulatory mechanisms for therapy in disease conditions associated with TMEM16A. Before 
effective therapy can be designed a clear and complete picture of TMEM16A’s regulation must be 
obtained. 
4.4 Figures and tables  
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Figure 4-1. Phosphate position is key mediating TMEM16A-PI(4,5)P2 interaction 
 Water-soluble analogs of the membrane phosphoinositides were applied to inside-out excised patches once current 
had stably rundown. Currents were recorded at -60 mV. (A) Representative  plot  of  normalized current fit with a 
single exponential (red line) recorded during 100-150 ms steps to -60 versus time, after patch excision. 2 mM Ca2+ 
was applied at 10 s as denoted by the grey bar. (B) Representative plot of normalized currents versus time, before and 
during application of 100 μM diC8-PI(4,5)P2 with 2 mM Ca2+. (C) Box plot distribution of the fold current recovered 
after the application of 100 μM diC8-PI(3,4,5)P3 with added Ca2+ (N=5), 100 μM diC8-PI(3,4)P2 with added Ca2+ 
(N=5), 100 μM diC8-PI(3,4)P2 with added Ca2+ (N=5), 100 μM diC8-PI(3)P with added Ca2+ (N=5), 100 μM diC8-
PI(4)P with added Ca2+ (N=9) and 100 μM diC8-PI(5)P with added Ca2+ (N=5). The fold change  in  current  recovered  
was calculated as change in current upon application of each phosphoinositide with Ca2+. The blue lines denote the 
box plot distribution of fold current recovered from patches recorded with 100 μM diC8-PI(4,5)P2 with Ca2+, where 
the solid blue line represents the median value and the dashed lines represent the control data distribution from 25-
75%. Representative plots of normalized currents versus time, before and during application of diC8-PIP3 with added 
Ca2+ (D), diC8-PI(3,4)P2 with added Ca2+ (E), diC8-PI(3,4)P2 with added Ca2+ (F), diC8-PI(4)P with added Ca2+ (G), 
diC8-PI(3)P with added Ca2+ (H) and diC8-PI(5)P with added Ca2+ (I). * indicates a P< 0.05 as determined by t-test. 
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Table 4-1. Ca2+ activates PLC to speed patch rundown 
Condition Concentration Tau, t (s) Number of trials 
Control (Ca2+) 2 mM 86 ± 7.6 N = 9 
Xl-VSP --- 61.2 ± 3.0 N = 5 
Ca2+ 100 µM 755 ± 388 N = 5 
Ca2+ 500 µM 216.3 ± 45 N = 5 
Alternating 2 mM 
and 0 mM Ca2+ 
0 and 2 mM 47.1 ± 4.9 N = 4 
Ni2+ 2 mM 468.6 ± 176 N = 5 
Mg2+ 2 mM --- N = 5 
U-73343 1 µM 128 ± 38 N = 4 
U-73122 1 µM 253 ± 83 N = 5 
 
The mean ± SEM for the indicated measurements taken from excised inside-out patches. The t was obtained by fitting 
plots of the currents versus time with single exponential functions. 
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Figure 4-2. Xl-VSP speeds TMEM16A current rundown but does not abolish TMEM16A currents 
Inside-out patch clamp recordings were conducted on macropatches excised from X. laevis oocytes expressing X1-
VSP.  (A) Schematic depicting a VSP tagged with GFP. (B) Confocal images depicting VSP expression at the plasma 
membrane of an oocyte. (C) Box plot distribution of the rate of  current  decay (t), measured by fitting plots of relative 
current versus time with single exponentials for the control (N=9) and VSP expressing (N=5). The central line denotes 
the median, the box denotes the distribution of 25-75 % of the data, and the whiskers represent 10-90 % of the data. 
(D) Top: voltage protocol used to activate the VSP. Bottom: representative  plot of normalized currents versus time 
following VSP activation. The grey dashed line represents a predicted control representing the control traces.  
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Figure 4-3. Different concentrations of Ca2+ result in different TMEM16A current profiles 
Inside-out patch clamp recordings were conducted on macropatches  excised  from X. laevis oocytes during the 
application of Ca2+. Representative nominal currents  recorded  during  100-150  ms steps to -60 mV before, during 
and after the application of Ca2+ at 2 mM (A), 20 μM (B), 50 μM (C), 100 μM (D) and 500 μM (E). 
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Figure 4-4. Lowering Ca2+ slows current rundown 
Inside-out patch clamp recordings were conducted on  macropatches excised from X. laevis oocytes during the 
application of varying concentrations of Ca2+. (A) Box plot distribution of the rate of current decay (t), measured by 
fitting plots of  relative current versus time with single  exponentials for the current recordings before, during and after 
the application of 100 μM Ca2+ (N=5), 500 μM Ca2+ (N=5) and alternating for 10s between 2 mM Ca and 0 mM Ca2+ 
(N=4). The dashed black line represents the median t for the control (N=9). Representative  plot of normalized currents 
versus time before, during and after the application of 100 μM Ca2+ (B), 500 μM Ca2+ (C). (D) Box plot distribution 
of the rate of current decay (t) current recordings before, during and after the application of alternating for 10s between 
2 mM Ca and 0 mM. (E) Representative plot of normalized currents versus time before, during and after the application 
of alternating 10 s intervals of 2 mM Ca and 0 mM Ca2+ . * indicates a P <0.05 as determined by t-test and compared 
to 2 mM Ca2+ control. 
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Figure 4-5. Substituting Ca2+ with other divalents slows current rundown 
Inside-out patch clamp recordings were conducted on  macropatches excised from X. laevis oocytes during the 
application of the divalents Ni2+and Mg2+. (A)  Box plot distribution of the rate of current  decay (t), measured  by  
fitting plots of relative current versus time with single  exponentials for the current recordings before, during and after 
the application of  2 mM Ni2+ (N=6). The dashed black line represents the median t for the control (N=9). 
Representative  plot of normalized currents versus time before, during and after the application of 2 mM Ni2+ (B) 2 
mM Mg2+ (N=4) (C). * indicates a P > 0.05 compared to 2 mM Ca2+ control. * indicates a P <0.05 compared to 2 mM 
Ca2+ control. P-values were determined by t-test. 
 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
t 
(s
) 
Figure 4-6. Inhibiting PLC slows current rundown 
Inside-out  patch  clamp  recordings  were  conducted on  macropatches  excised  from X.  laevis oocytes during the 
application of the general PLC inhibitor U-73122 and its inactive analog U-73343. (A) Schematic representing the 
Ca2+-sensitive PLC mediated depletion of PI(4,5)P2. (B)  Box plot distribution of  the  rate  of  current  decay  (t), 
measured by  fitting  plots of  relative current  versus  time with single  exponentials for the current recordings before, 
during and after the application of 1 μM U-73343 (N=4), and 1 μM U-73122 (N=6). Representative  plot of normalized 
currents versus time before, during and after the application 1 μM U-73343 (C) and 1 μM U-73122 (D). Grey dashed 
line represents controls recorded in 2 mM Ca2+. Green dashed line represents recordings conducted in 1 μM U-73343. 
* indicates P < 0.05 as determined by t-test. 
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5.0 Overall Discussion 
In this section, I will summarize the research I have conducted for my dissertation as well 
as what this research offers to the scientific community. I will also propose experiments that could 
be a guide for future research. 
5.1 Overview of dissertation research 
For my dissertation, I investigated two main questions: 1) what are the signaling 
mechanisms regulating TMEM16A gating? and 2) how do PI(4,5)P2 and Ca2+ regulate TMEM16A 
gating? To  answer these questions, I employed electrophysiology techniques that directly 
measured the activity of Xenopus TMEM16A in the oocytes of the African clawed frog, Xenopus 
laevis. Briefly, I have shown that TMEM16A requires both PI(4,5)P2 and Ca2+ to conduct Cl-  
currents. I have also shown that TMEM16A-evoked Cl- currents rundown and that the speed of 
rundown is dictated by Ca2+, suggesting a role for a Ca2+-sensitive PLC in the depletion of 
PI(4,5)P2 which regulates TMEM16A gating. 
5.2 Research implications for the PI(4,5)P2 regulation of TMEM16A 
In addition to managing the Cl- homeostasis required for the survival of most cells [133], 
TMEM16A is just as powerful at promoting disease. Since TMEM16A plays a role in promoting 
hypertension [135], a major gateway condition to cardiovascular and cerebrovascular disease 
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[101], and a factor contributing greater than 10 million preventable deaths every year [168], 
TMEM16A should be targeted for the development of novel forms of hypertensive therapy. 
However, targeting TMEM16A for therapy could have wide reaching consequences given that 
knocking out TMEM16A in mice is lethal [100]. Therefore, therapy could involve pharmaceutical 
targeting of TMEM16A’s regulation. Now that I have demonstrated that PI(4,5)P2 is required for 
TMEM16A activation and that the phosphate at position 4 on PI(4,5)P2  is instrumental for this 
interaction, drugs can be designed to disrupt or enhance this interaction. 
5.3 Research implications for the Ca2+ regulation of TMEM16A 
Like PI(4,5)P2, Ca2+ is also required to open TMEM16A channels. However, PI(4,5)P2 is 
kept in homeostatic balance in the plasma membrane while Ca2+ fluctuates relative to a cell’s needs 
for signaling, therefore making it difficult to target the TMEM16A-Ca2+ relationship without 
having off target effects. My research points to a Ca2+-sensitive PLC speeding TMEM16A 
rundown. The Ca2+ modulation of the PLC can be used as a tool to alter PI(4,5)P2, DAG and IP3 
levels. This could be important in studying the regulation of other ion channels regulated by 
PI(4,5)P2 using the excised inside-out patch technique. 
5.4 Unanswered questions about TMEM16A regulation 
Future studies could focus on resolving the Cl- pore. Perhaps a first step would be to resolve 
a structure for TMEM16A in a Ca2+ and PI(4,5)P2 bound state so that a likely pore can be identified. 
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Studies have identified PI(4,5)P2 [136, 137] and Ca2+ [50] binding sites on TMEM16A but the Cl- 
pore has not been resolved. Perhaps, purifying TMEM16A channels containing a mutation that 
makes them constitutively active could help resolve the Cl- pore. TMEM16A gating is controlled 
by the shifting of the a-helix on TM6 [46, 152]. This movement is enabled by a glycine hinge 
located at mTMEM16A G644 [46, 152]. G644P mutation results in constitutively active 
TMEM16A channels [46, 152] that I propose be used when resolving TMEM16A’s Cl- pore. 
High concentrations of Ca2+ activate TMEM16A and the PLC that depletes PI(4,5)P2. A 
major question that requires additional study is how PI(4,5)P2 can both encourage TMEM16A 
currents by forming electrostatic interactions [136, 137] and also be hydrolyzed to DAG and IP3 
(thereby depleting PI(4,5)P2, to activate TMEM16A) [163]. One explanation for this could be that 
in X. laevis oocytes, which mature into fertilization competent eggs [155], the egg is equipped with 
enough PI(4,5)P2 to do both. This is supported by data showing that at fertilization PI(4,5)P2 levels 
double [169]. By increasing PI(4,5)P2 at the membrane, the egg may have enough PI(4,5)P2 to 
both hydrolyze and to stay at the membrane to potentiate TMEM16A channels once the fast block 
is initiated. Since the membrane remains depolarized for at least 40 minutes [156], both Ca2+ and 
PI(4,5)P2 could be present. Alternatively, the channel may become inactive and the pumps that 
bring Cl- back could be unfunctional. To better understand TMEM16A regulation, I would like to 
evaluate if other cell types such as smooth muscle cells, known to express TMEM16A, would 
demonstrate a similar Ca2+-TMEM16A-PI(4,5)P2 relationship in excised inside-out patches. 
Notably, other studies demonstrating that PI(4,5)P2 potentiates TMEM16A have used exogenous 
expression systems such as HEK293 cells [68, 78] that do not have a reported physiological need 
comparable to the fast block in X. laevis eggs.  
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Lastly, the PLC in the oocyte whose activity is increased by Ca2+ has not been identified. 
The oocyte expresses PLCg and PLCb subtypes [125, 162, 163], and the general PLC inhibitor 
U73122 is not specific for either subtype [151]. At this time, no potent inhibitors for specific PLC 
subtypes exist. Additional studies investigating which PLC(s) are involved in regulating 
TMEM16A could be informative. I propose to inject PLC subtype specific siRNAs in X. laevis 
oocytes and measure the rate of current rundown. It is possible that being able to distinguish 
between the PLCs could help reduce off target effects in the case that silencing one PLC subtype 
over the other slows current rundown. 
5.5 Dissertation research conclusions 
The overall goal of my dissertation has been to determine how a disease implicated channel 
is regulated using X. laevis oocytes as a model. Understanding how the well-established CaCC 
TMEM16A is regulated adds new insight into mechanisms of a proteins involved in debilitating 
diseases. Remembering that hypertension affects 1 billion people world-wide [168], this new 
research could have far reaching implications for how we think about and ultimately, how we treat 
diseases associated with TMEM16A.  
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